Other secondary gonarthrosis

SCND_OTH_KNEEARTHROSIS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 M17.5
  • Hospital discharge: ICD-9 7152F
  • Cause of death: ICD-10 M17.5
  • Cause of death: ICD-9 7152F

2 out of 7 registries used, show all original rules.

1952

4. Check minimum number of events

None

1952

5. Include endpoints

None

1952

6. Filter based on genotype QC (FinnGen only)

1952

Control definitions (FinnGen only)

Control exclude
KNEE_ARTHROSIS

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M17
Name in latin
Alia gonarthrosis secundaria

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 13147 6589 6446
Only index persons 11182 5819 5363
Unadjusted period prevalence (%)
Whole population 0.18 0.19 0.18
Only index persons 0.21 0.21 0.20
Median age at first event (years)
Whole population 56.46 59.11 53.59
Only index persons 54.68 57.72 51.40

-FinnGen-

Key figures

All Female Male
Number of individuals 1952 1030 922
Unadjusted period prevalence (%) 0.38 0.35 0.41
Median age at first event (years) 54.82 56.03 53.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1732
Matched controls
17320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
7152F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, secondary[OSTEORTHROSIS SECUNDARIA,POLVI]
+∞
323.0
357
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
24.4
323.0
660
426
M17.5
ICD-10 Finland
Other secondary gonarthrosis
12052.5
323.0
1403
6
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
30.1
323.0
547
261
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
38.6
323.0
488
174
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
221.6
323.0
504
32
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
715.4
323.0
707
17
M17.1
ICD-10 Finland
Other primary gonarthrosis
74.0
323.0
1024
331
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
187.6
289.4
296
19
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
295.9
253.9
253
10
L15
ICPC
Knee symptom/complaint
6.4
205.9
655
1510
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
8.8
194.8
460
680
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
10.1
188.2
405
507
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
9.3
186.0
422
579
B01AB05
ATC
enoxaparin; parenteral
4.7
185.7
878
3096
WX320
NOMESCO Finland
Spinalanesthesy
5.2
182.2
708
2017
L90
ICPC
Osteoarthrosis of knee
17.6
163.2
265
176
1220
FHL
Arthroscopy
14.1
158.8
283
236
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
145.9
138
*
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
20.7
145.7
222
122
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.8
142.6
460
1010
N02AX02
ATC
tramadol; systemic, rectal
3.7
141.5
1029
4928
M09AX01
ATC
hyaluronic acid; parenteral
16.4
138.3
230
160
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
27.6
136.6
190
77
M01AX05
ATC
glucosamine; oral
4.6
133.0
555
1604
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
8.0
132.5
326
489
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
7.3
130.8
343
566
WX111
NOMESCO Finland
Local infiltration anesthesia
33.7
127.4
168
55
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
17.5
124.3
201
129
NG1DA
NOMESCO Finland
X-ray of knees
52.1
123.1
148
31
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
5.9
122.6
382
789
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
8.3
122.5
291
410
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
14.0
121.5
216
175
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
14.8
119.2
206
156
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
9.6
107.8
232
274
A07EC01
ATC
sulfasalazine; oral, rectal
5.8
105.8
329
668
M01AH05
ATC
etoricoxib; oral
3.1
105.4
1205
7314
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.0
104.1
994
5319
1221
FHL
Arthroscopy and meniscus surgery
15.0
91.9
157
114
P01BA02
ATC
hydroxychloroquine; oral
5.2
89.8
308
692
L04AA13
ATC
leflunomide; oral
11.3
82.3
160
154
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
11.0
78.1
154
152
N02AJ06
ATC
codeine and paracetamol; systemic
2.7
78.1
772
3967
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.6
75.2
238
482
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
158.8
72.6
76
5
ZXA00
NOMESCO Finland
Right side
2.8
71.2
623
2934
NG2AA
NOMESCO Finland
Patella X-ray examination
23.5
70.5
102
46
L88
ICPC
Rheumatoid/seropositive arthritis
7.5
69.9
174
255
M17.4
ICD-10 Finland
Other secondary gonarthrosis, bilateral
246.6
69.8
71
*
ZXA05
NOMESCO Finland
Left side
2.8
69.5
586
2690
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
10.6
69.4
139
141
1225
FHL
Arthroscopy and other therapeutic procedure
23.0
68.7
100
46
NGU20
NOMESCO Finland
Removal of internal fixation device from knee or lower leg
15.1
65.6
111
78
71301
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) genus
+∞
65.0
62
*
N03AX12
ATC
gabapentin; oral
3.3
64.5
382
1373
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.8
64.1
308
939
1223
FHL
Arthroscopy and articular cartilage surgery
30.7
63.5
85
29
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.4
63.3
801
4549
SPAT1153
SPAT
Removal of sutures
2.5
63.2
671
3472
S18
ICPC
Laceration/cut
2.4
61.7
828
4824
M01AH01
ATC
celecoxib; oral (coxibs)
3.0
61.6
435
1761
N02BE01
ATC
paracetamol; systemic, rectal
3.2
61.1
1555
12646
NGC30
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, special prosthesis
318.6
60.7
61
*
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
4.7
59.9
218
510
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
29.1
57.5
78
28
WX002
NOMESCO Finland
Sedation and analgesia
2.8
57.2
457
1987
NGT60
NOMESCO Finland
Forcible manipulation of knee joint
126.4
57.2
61
5
B01AF01
ATC
rivaroxaban; oral
3.6
57.1
284
885
H02AB06
ATC
prednisolone; systemic
2.3
56.9
918
5764
NGK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of knee or lower leg
152.6
56.2
59
*
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
23.9
55.8
80
35
M17.2
ICD-10 Finland
Post-traumatic gonarthrosis, bilateral
+∞
55.5
53
*
M01AE03
ATC
ketoprofen; systemic, rectal
2.3
55.2
789
4656
M01AH02
ATC
rofecoxib; oral
3.2
54.8
332
1200
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.9
54.6
250
725
B01AX06
ATC
[U] rivaroxaban; oral
13.5
53.7
95
74
NGC20
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, normal prosthesis
+∞
53.4
51
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
9.6
52.5
110
121
9314
FHL
Total knee endoprosthesis (also includes patellar part)
115.7
52.1
56
5
M25.5
ICD-10 Finland
Pain in joint
2.4
50.9
558
2863
7170A
ICD-9 Finland
Internal derangement of knee, Old bucket handle tear of medial meniscus
12.9
50.5
91
74
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
7.4
50.3
124
178
S83.2
ICD-10 Finland
Tear of meniscus, current
4.6
49.6
184
436
M79.6
ICD-10 Finland
Pain in limb
2.2
49.2
686
3937
TNG10
NOMESCO Finland
Puncture of knee
19.5
49.1
75
40
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
24.7
48.7
69
29
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
23.5
48.7
70
31
9312
FHL
Osteotomy of tibia or femur
491.1
48.6
48
*
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.7
48.5
116
159
NGC00
NOMESCO Finland
Exchange of a loose part of prosthesis in knee joint
+∞
48.1
46
*
N03AX16
ATC
pregabalin; oral
2.4
47.6
489
2408
M01AC06
ATC
meloxicam; systemic, rectal
2.2
46.9
713
4230
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
46.8
852
5464
A02BC02
ATC
pantoprazole; systemic
2.1
46.8
1194
8822
S83.5
ICD-10 Finland
Sprain and strain involving (anterior)(posterior) cruciate ligament of knee
7.3
46.4
115
166
X59
ICD-10 Finland
Exposure to unspecified factor
2.6
46.1
387
1702
NGF20
NOMESCO Finland
Operation for osteochondritis of knee, open
164.4
46.0
48
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
7.7
45.6
109
149
L04AB04
ATC
adalimumab; parenteral
10.3
45.2
91
93
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
6.5
44.4
120
196
A02BC01
ATC
omeprazole; systemic
2.2
42.1
552
3032
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.4
41.5
222
723
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
41.3
552
3051
84400
ICD-8 Finland
Sprains and strains of knee and leg
10.7
40.7
80
78
M13.9
ICD-10 Finland
Arthritis, unspecified
3.7
40.5
191
562
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
14.0
40.5
70
52
M01CB01
ATC
sodium aurothiomalate; parenteral
9.7
40.2
83
89
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.2
40.0
163
421
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
39.8
248
898
L04AB01
ATC
etanercept; parenteral
11.1
39.5
76
71
M16.1
ICD-10 Finland
Other primary coxarthrosis
3.0
39.5
251
921
M01AB05
ATC
diclofenac; systemic, rectal
2.0
39.3
1191
9065
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
39.1
364
1680
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
39.1
193
589
E883A
ICD-9 Finland
Fall into hole or other opening in surface
4.2
37.9
153
392
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
37.9
337
1515
WZA00
NOMESCO Finland
Short statement of of health and health related matters
4.4
37.7
145
354
1222
FHL
Arthroscopy and synovial surgery
14.4
37.6
64
46
M01AX17
ATC
nimesulide; oral
2.2
37.1
493
2691
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
194.1
36.9
38
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.3
36.8
205
685
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
6.0
36.7
104
181
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
36.0
424
2188
WZA90
NOMESCO Finland
Other doctors statement
2.2
36.0
425
2193
J01DB01
ATC
cefalexin; oral
2.1
36.0
1410
11637
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
35.7
249
968
9255
FHL
Joint auger removal
18.3
35.5
55
31
NGE35
NOMESCO Finland
Plastic repair of ligament of knee not using prosthetic material, anterior cruciate, arthroscopic
8.6
35.4
78
94
M48.0
ICD-10 Finland
Spinal stenosis
2.7
34.7
260
1054
8442A
ICD-9 Finland
Sprains and strains of knee and leg, Cruciate ligament of knee[DISTORSIO/DISTEN/RUPT.LIG.CRUCIATI ANTERIORIS GENUS]
20.2
34.1
51
26
B01AB04
ATC
dalteparin; parenteral
4.2
33.7
135
343
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.1
32.8
460
2549
9254
FHL
Arthrotomy (includes biopsy, revision, loose removal, fixation, and similar procedures)
16.0
32.6
53
34
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
9.4
32.5
68
75
9243
FHL
Plastic of the patella and its tendons
12.5
32.1
58
48
A02BC05
ATC
esomeprazole; systemic
1.9
31.9
734
4894
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.6
31.9
268
1158
WX212
NOMESCO Finland
Femoral plexus blockade
8.4
31.7
71
88
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
31.6
622
3923
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
9.9
31.5
64
67
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
16.0
30.8
50
32
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
30.4
546
3316
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
8.8
30.3
66
78
L40.5
ICD-10 Finland
Arthropathic psoriasis
8.0
30.1
69
89
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
6.2
30.0
83
140
NGB10
NOMESCO Finland
Primary partial prosthetic replacement of knee joint, demi prosthesis
69.2
30.0
34
5
M01AE02
ATC
naproxen; oral, rectal
1.8
29.7
955
7058
M02AA07
ATC
piroxicam; topical
1.8
29.3
677
4485
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.3
28.8
157
515
L28
ICPC
Limited function/disability (L)
2.3
28.6
301
1455
N02AA05
ATC
oxycodone; systemic
2.4
28.6
278
1293
9057A
ICD-9 Finland
Late effects of musculoskeletal and connective tissue injuries, Late effect of sprain and strain without mention of tendon injury
17.1
28.5
45
27
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.0
28.3
57
59
SAA02
NOMESCO Finland
Basic examination of mouth
1.8
28.1
1023
7795
9244
FHL
Plastic or reconstruction of ligaments of the knee other than the lumbar region
39.7
28.1
35
9
SPAT1202
SPAT
Intra-articular injection
5.3
28.0
88
174
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.0
28.0
117
309
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
28.0
201
789
WX702
NOMESCO Finland
Supraglottic ventilation device
3.6
27.9
132
387
NF1AA
NOMESCO Finland
Hip X-ray examination
2.8
27.9
191
729
E8859
ICD-8 Finland
Fall on same level from slipping, stumbling or tripping
4.5
27.9
102
237
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
3.2
27.9
154
509
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
27.7
497
3000
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
3.8
27.0
119
329
WX110
NOMESCO Finland
Local anesthesy
1.8
27.0
1137
9011
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
5.8
26.8
77
137
L17
ICPC
Foot/toe symptom/complaint
1.9
26.3
440
2578
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
4.1
26.3
106
271
7174A
ICD-9 Finland
Internal derangement of knee, Derangement of lateral meniscus
20.4
25.7
38
19
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
9.7
25.5
52
55
NGC99
NOMESCO Finland
Other secondary prosthetic replacement inknee joint, other or unspecified
+∞
25.1
24
*
NGC60
NOMESCO Finland
Exchange or addition of patellar part
+∞
25.1
24
*
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
7.7
24.7
58
78
M23.5
ICD-10 Finland
Chronic instability of knee
16.6
24.5
39
24
NG1AD
NOMESCO Finland
Knee CT examination
10.5
24.1
47
46
M19.2
ICD-10 Finland
Other secondary arthrosis
8.6
23.9
52
62
X58
ICD-10 Finland
Exposure to other specified factors
2.3
23.8
252
1216
R4110
NOMESCO Finland
Physiotherapy
1.8
23.6
481
3002
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
3.0
23.6
140
486
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
6.5
23.4
61
96
9311
FHL
Knee cleansing surgery (synovectomy, debridement)
47.4
23.4
28
6
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
5.1
23.3
75
153
M23.4
ICD-10 Finland
Loose body in knee
28.7
23.2
31
11
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
4.1
23.1
92
233
J01FF01
ATC
clindamycin; systemic
1.8
22.8
479
3018
NGF40
NOMESCO Finland
Repair of defect of cartilage in the knee joint with transplant
84.6
22.7
25
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.9
22.2
141
511
M25.0
ICD-10 Finland
Haemarthrosis
11.0
22.2
42
39
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.0
22.2
91
237
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
12.0
22.0
40
34
9165
FHL
Removal of osteosynthesis material
5.3
21.9
68
133
M16.7
ICD-10 Finland
Other secondary coxarthrosis
12.4
21.8
39
32
M01AE01
ATC
ibuprofen; systemic, rectal
1.9
21.8
1493
13227
NGS10
NOMESCO Finland
Incision and debridement of infection of knee joint
39.2
21.7
27
7
NGE10
NOMESCO Finland
Incision or suture of capsule of knee joint
20.3
21.7
32
16
M07.3
ICD-10 Finland
Other psoriatic arthropathies
7.7
21.4
50
67
N06AA09
ATC
amitriptyline; systemic
2.3
21.4
207
952
M93.2
ICD-10 Finland
Osteochondritis dissecans
26.8
21.4
29
11
L04AB06
ATC
golimumab; parenteral
14.1
21.3
36
26
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.8
21.3
93
256
R06.0
ICD-10 Finland
Dyspnoea
1.8
21.2
427
2641
M19.9
ICD-10 Finland
Arthrosis, unspecified
4.1
21.2
84
212
M01AH03
ATC
valdecoxib; oral
2.8
21.0
139
517
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
13.6
21.0
36
27
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
3.3
21.0
110
350
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.9
20.9
135
495
8360A
ICD-9 Finland
Dislocation of knee, Tear of medial cartilage or meniscus of knee, current
10.2
20.9
41
41
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
20.7
491
3198
J01DA01
ATC
[U] cefalexin; systemic
1.6
20.5
1036
8295
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
20.5
359
2115
M54.5
ICD-10 Finland
Low back pain
1.7
20.4
517
3432
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
7.8
20.4
47
62
C03CA01
ATC
furosemide; systemic
1.7
20.4
480
3116
M22.4
ICD-10 Finland
Chondromalacia patellae
4.8
20.3
68
145
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
3.1
20.2
114
381
N02AC04
ATC
dextropropoxyphene; oral
3.5
20.1
95
279
L04AA01
ATC
[U] ciclosporin; systemic
5.7
20.0
58
105
NHG20
NOMESCO Finland
Fusion of talocrural joint
19.1
20.0
30
16
WX720
NOMESCO Finland
Own respiration
3.6
19.9
91
261
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
7.0
19.8
49
72
M03BX02
ATC
tizanidine; oral
1.6
19.8
1022
8195
E66.01
ICD-10 Finland
Obesity due to excess calories
2.7
19.6
139
540
S80.0
ICD-10 Finland
Contusion of knee
3.0
19.6
118
414
WX402
NOMESCO Finland
General anaesthesia
2.0
19.6
294
1634
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.7
19.6
136
523
L04AA11
ATC
[U] etanercept; parenteral
17.9
19.6
30
17
M23.3
ICD-10 Finland
Other meniscus derangements
8.6
19.4
42
50
M23.8
ICD-10 Finland
Other internal derangements of knee
4.3
19.4
72
171
1224
FHL
Arthroscopy and loose removal
46.5
19.2
23
5
7178C
ICD-9 Finland
Internal derangement of knee, Other internal derangement of knee[LAESIO LIGAMENTI CRUCIATI]
22.8
19.1
27
12
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
4.3
19.1
72
174
R4120
NOMESCO Finland
Occupational therapy
2.8
19.0
129
489
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
18.7
177
804
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
7.8
18.4
42
55
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
4.0
18.3
75
196
9054A
ICD-9 Finland
Late effects of musculoskeletal and connective tissue injuries, Late effect of fracture of lower extremities
10.5
18.2
35
34
S83.0
ICD-10 Finland
Dislocation of patella
9.4
18.1
37
40
WX725
NOMESCO Finland
Noninvasive ventilation
3.1
18.1
103
348
J04AB02
ATC
rifampicin; systemic
7.5
18.0
42
57
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
8.8
17.9
38
44
NGU00
NOMESCO Finland
Removal of partial prosthesis from knee joint, other or unspecified
+∞
17.7
17
*
E929A
ICD-9 Finland
Late effects of accidental injury[YLIRASITUS JA KESTOKYVYN YLIT LIIKK AIH TAPAT]
9.0
17.7
37
42
L08
ICPC
Shoulder symptom/complaint
1.8
17.7
320
1898
ACC51
NOMESCO Finland
Release of median nerve
2.6
17.6
133
535
7327A
ICD-9 Finland
Osteochondropathies, Osteochondritis dissecans[OSTEOCHONDRITIS DISSECANS GENUS]
29.1
17.4
23
8
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
17.4
672
4949
B01AB10
ATC
tinzaparin; parenteral
2.5
17.4
139
579
NHG22
NOMESCO Finland
Fusion of subtalar joint
14.0
17.3
29
21
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.0
17.2
243
1315
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
17.2
983
7941
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.7
17.2
121
468
M01AX01
ATC
nabumetone; oral
3.1
17.2
94
310
M01AB55
ATC
diclofenac, combinations; oral
2.5
17.1
140
591
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
5.9
16.8
47
82
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
7.3
16.8
40
56
S89.9
ICD-10 Finland
Unspecified injury of lower leg
3.9
16.8
69
181
7110F
ICD-9 Finland
Arthropathy associated with infections, Pyogenic arthritis[ARTHRITIS PURULENTA, POLVI]
+∞
16.7
16
*
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
9.3
16.7
34
37
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
3.0
16.6
98
340
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.3
16.6
62
149
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
5.9
16.5
46
80
RF210
NOMESCO Finland
NA
4.0
16.5
67
174
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
10.9
16.5
31
29
NG1AA
SPAT
NA
3.5
16.4
78
232
SPAT1229
SPAT
Assessment of need for aid
2.4
16.4
149
663
M02AA10
ATC
ketoprofen; topical
1.9
16.3
270
1545
WX704
NOMESCO Finland
Intubation
2.4
16.1
140
610
L04AB05
ATC
certolizumab pegol; parenteral
16.9
16.1
25
15
SPAT1263
SPAT
Sampling
1.6
16.0
669
4994
L03
ICPC
Low back symptom/complaint
1.7
15.9
370
2367
Z01.2
ICD-10 Finland
Dental examination
1.6
15.8
611
4471
SPAT1204
SPAT
Arthrocentesis
11.3
15.8
29
26
J01AA02
ATC
doxycycline; systemic
1.6
15.7
1300
11333
L04AA17
ATC
[U] adalimumab; parenteral
15.8
15.7
25
16
9232
FHL
Knee ligament and / or capsule injury repair surgery
10.5
15.7
30
29
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
15.7
367
2350
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
15.7
430
2878
M01CB03
ATC
auranofin; oral
7.6
15.7
36
48
N06AX21
ATC
duloxetine; oral
2.1
15.7
181
902
NGB50
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - connected prosthesis
161.4
15.5
16
*
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.2
15.5
156
730
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
3.0
15.5
89
304
S83.3
ICD-10 Finland
Tear of articular cartilage of knee, current
7.1
15.4
37
53
E66.8
ICD-10 Finland
Other obesity
3.0
15.3
88
301
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
16.2
15.2
24
15
M22.0
ICD-10 Finland
Recurrent dislocation of patella
10.5
15.2
29
28
72221
ICD-8 Finland
Osteochondrosis, Dissecans
17.9
15.2
23
13
J01FA10
ATC
azithromycin; systemic
1.5
15.1
889
7140
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
20.2
15.1
22
11
L13
ICPC
Hip symptom/complaint
1.9
15.1
256
1477
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.2
15.0
80
260
M15
ICD-10 Finland
Polyarthrosis
3.1
14.9
85
287
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
14.9
232
1296
A02BA02
ATC
ranitidine; systemic
1.7
14.8
338
2145
NF1DA
NOMESCO Finland
X-ray of hips
4.1
14.8
57
142
W19
ICD-10 Finland
Unspecified fall
2.1
14.7
167
823
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
13.3
14.7
25
19
R03AC02
ATC
salbutamol; inhalant
1.5
14.5
803
6344
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.8
14.5
97
365
SPAT1301
SPAT
No procedures
1.6
14.5
502
3562
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
10.1
14.5
28
28
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
7.9
14.3
32
41
7183F
ICD-9 Finland
Other derangement of joint, Recurrent dislocation of joint[LUXATIO HABITUALIS, POLVI]
17.1
14.3
22
13
9294
FHL
Endoprosthesis replacement of the entire hip joint (eg Charnley)
9.2
14.2
29
32
WX204
NOMESCO Finland
Axillary plexus blockaced
3.3
14.2
71
220
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.6
14.2
430
2948
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
14.1
1083
9145
H02AB04
ATC
methylprednisolone; systemic
1.8
14.1
248
1446
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
14.1
863
6949
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
14.0
189
999
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
13.9
215
1198
J01MA12
ATC
levofloxacin; systemic
1.7
13.9
308
1935
S83.4
ICD-10 Finland
Sprain and strain involving (fibular)(tibial) collateral ligament of knee
3.5
13.8
64
187
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
4.4
13.8
49
113
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
13.8
254
1504
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
4.6
13.8
47
104
A02BC03
ATC
lansoprazole; oral
1.6
13.8
487
3464
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.3
13.7
127
570
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
10.5
13.7
26
25
L04AA24
ATC
abatacept; parenteral
12.1
13.6
24
20
J01CA04
ATC
amoxicillin; systemic
1.5
13.6
1270
11140
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
13.5
669
5132
7152E
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, secondary[OSTEORTHROSIS SECUNDARIA,LONKKANIVEL]
34.3
13.5
17
5
NGE15
NOMESCO Finland
Incision fo capsule of knee joint, arthroscopic
34.3
13.5
17
5
M01AB01
ATC
indometacin; systemic, rectal
2.2
13.5
145
698
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
3.4
13.4
65
197
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
13.4
465
3288
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
3.3
13.4
67
208
R51.80
ICD-10 Finland
Headache
1.9
13.4
216
1222
NK4EA
NOMESCO Finland
Joint X-ray examintion with load or wrench not elsewhere classified
18.4
13.4
20
11
WZA10
NOMESCO Finland
Long statement of health and health related matters
5.3
13.3
40
77
L04AX01
ATC
azathioprine; systemic
2.8
13.3
86
317
L12
ICPC
Hand/finger symptom/complaint
1.9
13.3
217
1233
M70.6
ICD-10 Finland
Trochanteric bursitis
1.9
13.3
195
1067
B01AX05
ATC
fondaparinux; parenteral
10.5
13.2
25
24
S72.4
ICD-10 Finland
Fracture of lower end of femur
9.8
13.2
26
27
A28
ICPC
Limited function/disability NOS
1.8
13.2
241
1423
E889A
ICD-9 Finland
OTHER OR MORE SPECIFIED FALLING OR FALLING
5.9
13.2
36
62
M25.4
ICD-10 Finland
Effusion of joint
5.7
13.2
37
66
Z50.1
ICD-10 Finland
Other physical therapy
2.5
13.1
103
426
H02BX01
ATC
methylprednisolone, combinations; systemic
2.6
13.0
97
391
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
4.0
13.0
51
130
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.2
12.9
132
624
M16.6
ICD-10 Finland
Other secondary coxarthrosis, bilateral
50.4
12.8
15
*
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.9
12.8
182
986
NDL52
NOMESCO Finland
Tenosynovectomy of hand
10.6
12.7
24
23
J01FA06
ATC
roxithromycin; oral
1.5
12.7
641
4919
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
5.5
12.7
37
69
J01MA02
ATC
ciprofloxacin; systemic
1.5
12.7
612
4649
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
12.5
795
6386
NGB60
NOMESCO Finland
Primary partial prosthetic replacement of knee joint, patellar and femoral part
+∞
12.5
12
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
12.5
768
6134
9256
FHL
Synovectomy (knee 9311)
20.2
12.5
18
9
8361A
ICD-9 Finland
Dislocation of knee, Tear of lateral cartilage or meniscus of knee, current
20.2
12.5
18
9
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
12.4
250
1522
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
5.0
12.4
39
80
UJF32
NOMESCO Finland
Coloscopy
1.6
12.3
416
2913
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
12.2
203
1159
XX9XE
NOMESCO Finland
Other ultrasound examination
6.8
12.2
30
45
M79.7
ICD-10 Finland
Fibromyalgia
3.3
12.1
61
191
9253
FHL
Manipulation under anesthesia or regression and plastering
8.7
12.0
25
29
B01AE07
ATC
dabigatran etexilate; oral
2.9
12.0
74
266
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
11.9
862
7080
M01AE11
ATC
tiaprofenic acid; oral, rectal
2.7
11.9
79
298
9112
FHL
Correction osteotomy due to bone shape or positional defect
47.0
11.9
14
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
11.8
124
590
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
4.4
11.8
42
98
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.1
11.8
65
218
NDG30
NOMESCO Finland
Fusion of wrist, total
9.0
11.7
24
27
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
11.7
486
3565
M01AB16
ATC
aceclofenac; oral
2.8
11.7
73
265
L20
ICPC
Joint symptom/complaint NOS
3.1
11.7
63
208
83600
ICD-8 Finland
Dislocation of knee, Patellae, Non complicata (sive NUD)
16.5
11.7
18
11
H02AB07
ATC
prednisone; oral
1.7
11.6
235
1430
SPAT1325
SPAT
Vaccination
1.5
11.6
517
3848
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.7
11.6
256
1601
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
3.1
11.6
63
209
L01CB
ATC
Podophyllotoxin derivatives
19.1
11.6
17
9
K02.1
ICD-10 Finland
Caries of dentine
1.4
11.4
832
6817
D07AC01
ATC
betamethasone; topical
1.5
11.4
540
4066
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.7
11.4
76
288
M87.0
ICD-10 Finland
Idiopathic aseptic necrosis of bone
7.9
11.4
25
32
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
6.1
11.4
30
50
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
11.3
501
3723
A46
ICD-10 Finland
Erysipelas
1.7
11.3
227
1377
83690
ICD-8 Finland
Dislocation of knee, Patellae, Sequelae
35.3
11.3
14
*
9251
FHL
Drainage or flushing of the joint under anesthesia
35.3
11.3
14
*
8448A
ICD-9 Finland
Sprains and strains of knee and leg, Other specified sites of knee and leg[DISTORSIO/DISTENSIO/RUPT.LIGAMENTI GENUS MULTIPLEX]
35.3
11.3
14
*
ZXA10
NOMESCO Finland
Bilateral
1.6
11.1
291
1906
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.7
11.1
75
286
AA1AD
NOMESCO Finland
CT of head and brain
1.6
11.1
375
2618
WX400
NOMESCO Finland
Inhalation anesthesy
2.7
11.1
74
280
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
3.7
11.0
47
130
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.9
11.0
177
1002
SPAT1260
SPAT
Consultation of another employee
1.6
10.9
274
1774
7176A
ICD-9 Finland
Internal derangement of knee, Loose body in knee
43.6
10.9
13
*
R03BA05
ATC
fluticasone; inhalant
1.6
10.9
275
1781
L16
ICPC
Ankle symptom/complaint
2.0
10.9
148
787
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
10.8
361
2512
7148X
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies
17.9
10.7
16
9
A06AD11
ATC
lactulose; oral
1.7
10.6
223
1372
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
10.6
172
974
NFJ62
NOMESCO Finland
Internal fixation of fracture of other parts of femur with plate
7.0
10.6
25
36
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
10.5
259
1668
WX290
NOMESCO Finland
Other blockade of nerve
1.4
10.5
616
4826
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.3
10.4
92
406
R05
ICPC
Cough
1.6
10.4
319
2171
R06AE07
ATC
cetirizine; oral
1.4
10.4
629
4953
R60.0
ICD-10 Finland
Localized oedema
1.8
10.4
175
1003
9531
FHL
Arthrodesis of the hand joint
12.1
10.3
18
15
3006
Kela drug reimbursment
Baricitinib
32.7
10.3
13
*
L04AA37
ATC
baricitinib; oral
32.7
10.3
13
*
NH1AD
NOMESCO Finland
Ankle and foot CT
3.6
10.3
45
127
S82.1
ICD-10 Finland
Fracture of upper end of tibia
4.0
10.3
40
102
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
2.8
10.3
64
231
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
5.8
10.3
28
49
M15.3
ICD-10 Finland
Secondary multiple arthrosis
18.9
10.3
15
8
8448X
ICD-9 Finland
Sprains and strains of knee and leg, Other specified sites of knee and leg[DISTORSIO/DISTEN/RUPTURA GENUS ET CRURIS ALIA DEFIN]
9.6
10.3
20
21
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
3.4
10.2
49
149
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.4
10.2
49
149
E0000UV
ATC
NA
1.4
10.2
578
4488
N06AX11
ATC
mirtazapine; oral
1.5
10.2
475
3549
G56.2
ICD-10 Finland
Lesion of ulnar nerve
2.9
10.2
63
226
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
6.3
10.2
26
42
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.1
10.1
117
583
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
10.1
675
5407
TQW40
NOMESCO Finland
Remowal of suture of skin
2.0
10.1
123
627
M13.0
ICD-10 Finland
Polyarthritis, unspecified
4.5
10.1
34
76
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
10.1
413
3007
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
8.5
10.0
21
25
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
10.0
265
1736
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
10.0
322
2214
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
6.5
10.0
25
39
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
6.5
10.0
25
39
L91
ICPC
Osteoarthrosis other
4.4
10.0
35
81
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.6
10.0
71
279
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
10.0
77
315
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.1
10.0
54
180
293
Kela drug reimbursment
Baricitinib
40.3
10.0
12
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
9.9
546
4212
7151E
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, LONKKANIVEL]
7.7
9.9
22
29
NBB10
NOMESCO Finland
Primary partial prosthetic replacement of humero-scapular joint not using cement, other or unspecified
8.2
9.8
21
26
NBB20
NOMESCO Finland
Primary total prosthetic replacement of humero-scapular joint
5.7
9.8
27
48
NGW10
NOMESCO Finland
Reoperation for deep infection in in surgery of knee or lower leg
26.2
9.8
13
5
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
9.8
491
3720
L04AC10
ATC
secukinumab; parenteral
8.8
9.8
20
23
M01AC01
ATC
piroxicam; systemic, rectal
1.7
9.7
221
1390
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
2.6
9.7
67
260
J01CF02
ATC
cloxacillin; systemic
3.1
9.7
52
172
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
9.7
613
4849
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.6
9.7
32
70
8441A
ICD-9 Finland
Sprains and strains of knee and leg, Medial collateral ligament of knee
7.4
9.7
22
30
C07AB07
ATC
bisoprolol; oral
1.4
9.7
749
6138
J02AC01
ATC
fluconazole; systemic
1.4
9.7
574
4487
-1
NOMESCO Finland
NA
1.5
9.6
458
3435
WX200
NOMESCO Finland
Interscalenous plexus blockade
3.4
9.6
44
130
A01
ICPC
Pain general/multiple sites
2.0
9.6
121
624
M15.8
ICD-10 Finland
Other polyarthrosis
4.1
9.5
36
90
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
9.5
338
2380
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
3.5
9.5
43
126
L86
ICPC
Back syndrome with radiating pain
2.3
9.5
88
397
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
4.3
9.4
33
77
SPAT1262
SPAT
Handing over of treatment supplies
1.6
9.3
295
2019
M23
ICD-10 Finland
Internal derangement of knee
3.9
9.3
37
97
M06
ICD-10 Finland
Other rheumatoid arthritis
6.9
9.3
22
32
NGD25
NOMESCO Finland
Reinsertion of meniscus of knee, arthroscopic
6.9
9.3
22
32
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
9.3
206
1286
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
9.3
418
3092
M45
ICD-10 Finland
Ankylosing spondylitis
3.4
9.3
43
128
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.5
9.3
68
274
M02AA15
ATC
diclofenac; topical (antiinflammatory prep., non-steroids for topical use)
1.9
9.2
127
679
WX203
NOMESCO Finland
Infraclavicular plexus blockade
3.0
9.2
51
173
RF220
NOMESCO Finland
NA
4.4
9.2
32
74
G47.3
ICD-10 Finland
Sleep apnoea
1.5
9.2
324
2273
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.9
9.2
125
666
R03DC03
ATC
montelukast; oral
1.6
9.2
228
1467
M24.2
ICD-10 Finland
Disorder of ligament
5.2
9.1
27
53
7188E
ICD-9 Finland
Other derangement of joint, Other joint derangement, not elsewhere classified[MB ARTICULI, LIGAM ET CARTILAG AL DEF,LONKKANIVEL]
8.3
9.1
19
23
NGH20
NOMESCO Finland
Reduction of dislocation of knee joint, open
11.5
9.1
16
14
VALMI
NOMESCO Finland
NA
1.5
9.1
329
2326
NHG82
NOMESCO Finland
Fusion of other tarsal joint
5.6
9.1
25
45
R52.2
ICD-10 Finland
Other chronic pain
2.8
9.0
57
209
82200
ICD-8 Finland
Fracture of patella, Closed
15.7
9.0
14
9
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.5
9.0
71
295
M01AB08
ATC
etodolac; oral
2.0
9.0
117
612
M04AA01
ATC
allopurinol; systemic
1.7
9.0
198
1232
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
3.1
9.0
47
154
9056A
ICD-9 Finland
Late effects of musculoskeletal and connective tissue injuries, Late effect of dislocation
18.7
8.9
13
7
RF221
NOMESCO Finland
NA
18.7
8.9
13
7
T84.9
ICD-10 Finland
Unspecified complication of internal orthopaedic prosthetic device, implant and graft
18.7
8.9
13
7
J01FA09
ATC
clarithromycin; systemic
1.4
8.9
460
3492
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
5.8
8.9
24
42
KMAK
NOMESCO Finland
NA
1.4
8.9
745
6161
M79.1
ICD-10 Finland
Myalgia
1.7
8.9
174
1048
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
8.8
622
4994
NDF60
NOMESCO Finland
Operation for osteochondritis of a joint of hand,v
10.8
8.8
16
15
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
8.8
265
1795
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
2.4
8.7
73
315
SPAT1216
SPAT
Assessment of functional ability
1.6
8.7
223
1446
L34
ICPC
Musculoskeletal, Blood test
50.2
8.7
10
*
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
3.1
8.6
45
148
N05CF02
ATC
zolpidem; oral
1.6
8.6
254
1710
T84.4
ICD-10 Finland
Mechanical complication of other internal orthopaedic devices, implants and grafts
11.6
8.6
15
13
TNF11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in hip joint
16.4
8.6
13
8
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
10.1
8.5
16
16
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
8.5
51
183
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
7.4
8.4
19
26
S97
ICPC
Chronic ulcer skin
2.1
8.4
89
429
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
8.4
122
665
NB1AD
NOMESCO Finland
Shoulder CT examination
4.1
8.4
31
77
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
5.1
8.3
25
50
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.1
8.3
86
411
R05
ICD-10 Finland
Cough
1.5
8.3
278
1926
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
2.7
8.3
53
197
ZZH31
NOMESCO Finland
Bone allograft, small pieces
5.8
8.3
22
38
C08CA01
ATC
amlodipine; oral
1.4
8.3
562
4470
S29
ICPC
Skin symptom/complaint other
1.6
8.3
241
1617
M67.0
ICD-10 Finland
Short Achilles tendon (acquired)
7.1
8.3
19
27
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
8.2
366
2697
9284
FHL
Wrist ossification surgery
14.5
8.2
13
9
J01EA01
ATC
trimethoprim; systemic
1.5
8.1
360
2646
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
8.1
700
5788
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
8.1
154
921
NF3AA
NOMESCO Finland
Femur X-ray examination
3.5
8.1
36
105
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
8.1
191
1214
291
Kela drug reimbursment
Tofacitinib
17.2
8.1
12
7
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
8.0
338
2458
M76.6
ICD-10 Finland
Achilles tendinitis
2.2
8.0
74
338
M66.0
ICD-10 Finland
Rupture of popliteal cyst
4.0
8.0
30
76
S70.0
ICD-10 Finland
Contusion of hip
2.6
7.9
55
215
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.3
7.9
73
331
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
4.2
7.9
28
67
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
13.1
7.9
13
10
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
7.9
102
533
R01AD12
ATC
fluticasone furoate; nasal
1.4
7.9
387
2903
E882A
ICD-9 Finland
Fall from or out of building or other structure
5.4
7.8
22
41
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
7.8
538
4285
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
4.7
7.8
25
54
M19.8
ICD-10 Finland
Other specified arthrosis
2.6
7.8
57
228
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.3
7.8
69
306
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.9
7.8
108
582
N05CF01
ATC
zopiclone; oral
1.4
7.8
494
3881
A02BB01
ATC
misoprostol; oral
7.0
7.8
18
26
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
2.1
7.8
87
432
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
3.7
7.8
32
88
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
7.7
369
2752
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.9
7.7
115
634
B01AA03
ATC
warfarin; systemic
1.5
7.7
293
2085
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
5.1
7.7
23
46
9473
FHL
Local soft tissue removal or exploration (eg Bursa)
6.4
7.7
19
30
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
7.7
572
4607
D07AD01
ATC
clobetasol; topical
1.5
7.7
236
1600
J01DA06
ATC
[U] cefuroxime; systemic
1.6
7.6
221
1479
M11.2
ICD-10 Finland
Other chondrocalcinosis
11.9
7.6
13
11
9101
FHL
Bone biopsy
25.1
7.6
10
*
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
25.1
7.6
10
*
82121
ICD-8 Finland
Fracture of other and unspecified parts of femur, Lower end, closed
25.1
7.6
10
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.9
7.6
44
155
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.3
7.5
68
306
M20.1
ICD-10 Finland
Hallux valgus (acquired)
1.8
7.5
126
724
SPAT1312
SPAT
General health counselling
1.4
7.5
447
3471
A08AB01
ATC
orlistat; oral
7.1
7.5
17
24
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
7.1
7.5
17
24
T93.2
ICD-10 Finland
Sequelae of other fractures of lower limb
4.8
7.5
23
48
A02BX02
ATC
sucralfate; oral
2.2
7.4
68
309
M54.2
ICD-10 Finland
Cervicalgia
1.9
7.4
105
570
C01DA14
ATC
isosorbide mononitrate; oral
1.6
7.4
217
1455
71200
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis
13.4
7.4
12
9
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
7.4
509
4046
R4180
NOMESCO Finland
Podiatric therapy
4.4
7.3
25
58
9522
FHL
Synovectomy
8.4
7.3
15
18
9245
FHL
Reconstruction or plastic surgery of ankle ligaments
8.4
7.3
15
18
R02
ICPC
Shortness of breath/dyspnoea
1.7
7.3
166
1044
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
7.3
321
2354
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
3.0
7.3
40
137
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
10.9
7.3
13
12
9319
FHL
Other measure in this category
+∞
7.3
7
*
84490
ICD-8 Finland
NA
+∞
7.3
7
*
L11
ICPC
Wrist symptom/complaint
1.9
7.3
106
582
L89
ICPC
Osteoarthrosis of hip
2.5
7.3
54
220
D82
ICPC
Teeth/gum disease
1.4
7.2
461
3615
L29
ICPC
Musculoskeletal sympt/complt other
1.9
7.2
103
560
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
7.2
420
3243
NBG10
NOMESCO Finland
Acromioplastia
2.7
7.2
46
171
J45.8
ICD-10 Finland
Mixed asthma
2.6
7.2
50
196
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.6
7.2
50
196
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
7.2
114
643
R01AD08
ATC
fluticasone; nasal
1.4
7.1
397
3038
NGE60
NOMESCO Finland
Plastic repair of patellar ligaments, open
20.1
7.1
10
5
J01XX08
ATC
linezolid; systemic
6.6
7.1
17
26
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.8
7.1
124
720
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
3.6
7.1
30
85
205
Kela drug reimbursment
Chronic hypertension
1.4
7.1
429
3336
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.7
7.0
134
800
SPAT1310
SPAT
Counselling related to known health issue
1.4
7.0
456
3584
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.1
7.0
74
357
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
4.7
7.0
22
47
X57
ICD-10 Finland
Unspecified privation
3.0
7.0
37
124
OAB72
NOMESCO Finland
Weight control and weight loss guidance
7.0
7.0
16
23
9477
FHL
Cleansing or splitting of a tendon or tendon sheath (eg tenosynovectomy, tenolysis)
7.0
7.0
16
23
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.7
7.0
127
751
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.5
7.0
52
212
L99
ICPC
Musculoskeletal disease other
3.2
6.9
34
108
S83.7
ICD-10 Finland
Injury to multiple structures of knee
6.3
6.9
17
27
SDA02
NOMESCO Finland
Parodonthologic therapy
1.4
6.9
459
3619
H26.3
ICD-10 Finland
Drug-induced cataract
5.9
6.9
18
31
M01AE52
ATC
naproxen and esomeprazole; oral
2.4
6.9
55
233
E000001
ATC
NA
1.5
6.9
279
2009
RF421
NOMESCO Finland
NA
7.6
6.9
15
20
8449X
ICD-9 Finland
Sprains and strains of knee and leg, Unspecified site of knee and leg
7.6
6.9
15
20
NFC40
NOMESCO Finland
Repair of hip prosthesis by bone transplant to acetabulum
7.6
6.9
15
20
RT271
NOMESCO Finland
NA
13.8
6.9
11
8
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
4.1
6.9
25
62
M43.1
ICD-10 Finland
Spondylolisthesis
2.2
6.9
64
294
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.9
566
4616
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
6.9
371
2825
WZC30
NOMESCO Finland
Teaching
1.5
6.9
211
1433
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
2.9
6.9
40
142
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
6.8
88
461
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
6.8
400
3086
C09CA01
ATC
losartan; oral
1.4
6.8
363
2755
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.5
6.8
49
198
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.0
6.8
36
121
R53
ICD-10 Finland
Malaise and fatigue
1.5
6.8
271
1946
L04AA29
ATC
tofacitinib; oral
11.0
6.8
12
11
NFB50
NOMESCO Finland
Primary total prosthetic replacement of hip joint using cement
3.5
6.8
29
83
NGM20
NOMESCO Finland
Excision of synovial ganglion of knee or lower leg
9.3
6.8
13
14
N05CD07
ATC
temazepam; oral
1.6
6.8
197
1322
L01
ICPC
Neck symptom/complaint
1.6
6.8
185
1222
T93.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of lower limb
5.7
6.8
18
32
71005
ICD-8 Finland
Acute arthritis due to pyogenic organisms, Genus
40.2
6.8
8
*
9252
FHL
Plaster bandage placement or replacement (no fracture) in the operating room
16.8
6.7
10
6
NGF10
NOMESCO Finland
Total synovectomy of knee, open
16.8
6.7
10
6
N06AX16
ATC
venlafaxine; oral
1.6
6.7
183
1205
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
3.4
6.7
30
89
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.8
6.7
41
151
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.5
6.7
29
84
73105
ICD-8 Finland
Bursitis chronica, inflammation of the synovial membrane, bursa and tendon sheath
7.2
6.7
15
21
9527
FHL
Alloarthroplasty, implant or endoprosthesis
22.6
6.7
9
*
9964A
ICD-9 Finland
Complications peculiar to certain specified procedures, Mechanical complication of internal orthopaedic device, implant and graft
22.6
6.7
9
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.3
6.7
31
95
S21
ICPC
Skin texture symptom/complaint
1.6
6.7
175
1144
N62
ICD-10 Finland
Hypertrophy of breast
2.3
6.6
56
244
R42
ICD-10 Finland
Dizziness and giddiness
1.4
6.6
303
2236
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.2
6.6
64
299
NDG76
NOMESCO Finland
Fusion of DIP joint
4.6
6.6
21
46
-56
ICPC
Dressing/pressure/compress/tamponade
3.1
6.6
33
107
K07.60
ICD-10 Finland
Snapping jaw
2.2
6.6
62
287
9058A
ICD-9 Finland
Late effects of musculoskeletal and connective tissue injuries, Late effect of tendon injury
12.3
6.6
11
9
R2110
NOMESCO Finland
Giving the first information
1.9
6.6
96
528
SPAT1254
SPAT
Administration of medicine
1.5
6.6
196
1322
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.8
6.5
114
664
S72.3
ICD-10 Finland
Fracture of shaft of femur
4.8
6.5
20
42
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
6.5
234
1645
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.6
6.5
161
1037
Y0899
ICD-8 Finland
Investigation of musculoskeletal system
6.2
6.5
16
26
L50
ICPC
Musculoskeletal, Medication/prescr/renewal
6.2
6.5
16
26
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
6.4
281
2052
T82
ICPC
Obesity
2.4
6.4
50
212
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
6.4
70
346
B01AF02
ATC
apixaban; oral
1.7
6.3
139
867
NFH30
NOMESCO Finland
Reduction of dislocation prosthesis of hip joint, closed
6.6
6.3
15
23
9503
FHL
Tendon or tendon sheath cleansing surgery (tenosynovectomy)
8.2
6.3
13
16
M65.3
ICD-10 Finland
Trigger finger
2.1
6.3
67
326
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
6.3
145
916
H02AB08
ATC
triamcinolone; systemic
6.0
6.3
16
27
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.9
6.3
36
125
NDB60
NOMESCO Finland
Prosthetic replacement of MCP joint of finger
11.1
6.3
11
10
NCB20
NOMESCO Finland
Primary total prosthetic replacement of elbow joint
11.1
6.3
11
10
Z47.9
ICD-10 Finland
Orthopaedic follow-up care, unspecified
11.1
6.3
11
10
NF1AT
NOMESCO Finland
Puncture of hip joint with ultrasound guidance
11.1
6.3
11
10
L04AD01
ATC
ciclosporin; systemic
2.7
6.3
39
146
M05BA07
ATC
risedronic acid; oral
2.3
6.3
54
239
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
6.3
143
900
E83.30
ICD-10 Finland
Acid phosphatase deficiency
+∞
6.3
6
*
M362, D66
ICD-10 Finland
NA
+∞
6.3
6
*
NGC40
NOMESCO Finland
Secondary implantation of prosthesis in knee joint with allograft bone transplant
+∞
6.3
6
*
72903
ICD-8 Finland
Other diseases of joint, Hydrarthrosis
+∞
6.3
6
*
B02BD02
ATC
coagulation factor VIII; parenteral, topical, urethral
+∞
6.3
6
*
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
6.2
194
1320
J01FA15
ATC
telithromycin; oral
1.6
6.2
143
903
M76.9
ICD-10 Finland
Enthesopathy of lower limb, unspecified
4.1
6.2
22
54
P06
ICPC
Sleep disturbance
1.7
6.2
126
768
A07AA02
ATC
nystatin; oral
1.8
6.2
93
518
T78.3
ICD-10 Finland
Angioneurotic oedema
3.7
6.2
25
69
S46.1
ICD-10 Finland
Injury of muscle and tendon of long head of biceps
3.8
6.2
24
64
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
4.5
6.2
20
45
E8879
ICD-8 Finland
Other and unspecified fall
5.4
6.2
17
32
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
6.1
107
624
C01CA24
ATC
epinephrine; parenteral
1.9
6.1
81
431
M54.3
ICD-10 Finland
Sciatica
1.9
6.1
83
446
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
7.7
6.1
13
17
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
6.1
328
2492
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
6.1
269
1972
A08AA02
ATC
fenfluramine; oral (centrally acting antiobesity products)
4.7
6.1
19
41
72901
ICD-8 Finland
Other diseases of joint, Corpus liberum articuli
12.6
6.1
10
8
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
2.9
6.1
33
114
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
6.1
106
617
G04BD12
ATC
mirabegron; oral
1.6
6.1
141
894
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
6.0
206
1433
8363A
ICD-9 Finland
Dislocation of knee, Dislocation of patella, simple
6.7
6.0
14
21
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.5
6.0
46
190
M24.5
ICD-10 Finland
Contracture of joint
10.1
6.0
11
11
NDB78
NOMESCO Finland
Prosthetic replacement of several of finger or metacarpal
10.1
6.0
11
11
S19
ICPC
Skin injury other
2.3
6.0
53
239
82300
ICD-8 Finland
Fracture of tibia and fibula, Upper end or unspecified part, closed
5.2
6.0
17
33
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.7
6.0
126
776

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021788) Differential panel - Synovial fluid
202
184
12.13
193.52
2.1
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
233
266
9.81
190.35
2.3
1.6
e6/l
12379.0
10357.1
0.32
175
191
(3044941) Cell count panel - Synovial fluid
195
183
11.73
183.00
1.9
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
246
334
8.28
174.57
1.9
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
142
134
11.35
132.17
2.2
1.6
%
57.5
63.8
0.71
88
84
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
106
125
8.91
83.49
2.3
1.4
%
31.6
32.4
0.06
65
80
(3042936) Bacteria identified in Isolate by Culture
517
2180
2.87
83.41
2.5
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1145
7082
2.49
82.82
5.1
3.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
927
5383
2.38
74.79
8.3
5.9
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
67
53
13.06
69.39
2.2
1.3
%
4.0
2.0
—
17
9
(3032080) INR in Blood by Coagulation assay
1041
6566
2.25
66.47
9.7
9.8
inr
1.2
1.3
0.98
327
1848
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
127
254
5.28
60.57
2.0
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1537
11681
2.49
59.30
7.9
4.0
mm/h
14.6
12.6
5.17
1470
10723
(3006315) Basophils [#/volume] in Blood
1155
7890
2.14
56.70
9.3
5.9
e9/l
0.0
0.0
0.77
1039
6788
(3001604) Monocytes [#/volume] in Blood
1149
7858
2.12
55.92
9.3
5.9
e9/l
0.6
0.6
2.01
1034
6752
(3006504) Eosinophils/100 leukocytes in Blood
1091
7361
2.09
54.50
9.7
6.1
%
2.9
2.9
0.25
1046
6846
(3019069) Monocytes/100 leukocytes in Blood
1094
7392
2.09
54.39
10.2
6.4
%
8.8
8.8
0.11
1054
6905
(3019198) Lymphocytes [#/volume] in Blood
1162
8052
2.09
53.68
9.4
5.9
e9/l
2.0
1.9
0.27
1054
7052
(3018010) Neutrophils/100 leukocytes in Blood
1097
7442
2.08
53.68
9.6
6.0
%
58.1
57.6
0.86
1054
6948
(3013115) Eosinophils [#/volume] in Blood
1174
8176
2.09
53.38
9.5
6.1
e9/l
0.2
0.2
0.14
1064
7132
(3022096) Basophils/100 leukocytes in Blood
1063
7181
2.05
51.98
9.6
6.1
%
0.7
0.7
0.04
1018
6696
(3002030) Lymphocytes/100 leukocytes in Blood
1102
7551
2.06
51.71
9.7
6.2
%
27.2
27.4
0.25
1062
7027
(3010144) Erythrocytes [#/volume] in Synovial fluid
76
117
6.72
47.40
1.7
1.4
e6/l
8656.9
22900.3
0.69
43
82
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1564
12566
2.23
43.56
10.0
7.8
u/l
77.0
79.0
1.40
1508
11805
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
42
33
12.99
43.53
1.8
1.3
%
38.6
27.8
0.84
29
25
(3037467) Urinalysis macro (dipstick) panel - Urine
1386
10765
1.99
40.52
6.2
4.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1230
9252
1.89
38.69
11.4
9.5
e9/l
4.3
4.1
1.43
1119
8069
(3013826) Glucose [Moles/volume] in Serum or Plasma
1230
9455
1.81
33.81
5.5
5.0
mmol/l
6.7
6.8
0.30
1177
8895
(3030905) Polymorphonuclear cells [#/volume] in Blood
111
314
3.69
33.76
3.1
3.3
e9/l
4.0
4.1
0.30
111
314
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
113
326
3.62
33.38
3.2
3.5
%
56.5
57.9
0.51
113
326
(3035350) Ketones [Presence] in Urine by Test strip
1030
7599
1.75
31.74
5.0
3.7
estimate
0.0
0.0
0.00
227
1388
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
327
1670
2.15
31.66
3.6
3.5
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
32
28
11.60
30.96
1.5
1.1
g/l
36.0
34.7
—
18
10
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1790
15810
2.59
30.90
22.7
14.6
mg/l
22.9
25.2
2.33
1586
12427
(3031040) Bacteria [#/volume] in Urine by Automated count
1293
10228
1.78
30.74
5.5
4.4
e6/l
34.9
1940.6
—
8
160
(3024561) Albumin [Mass/volume] in Serum or Plasma
969
7071
1.74
30.66
5.4
5.0
g/l
34.8
35.3
2.43
922
6579
(3009261) Glucose [Presence] in Urine by Test strip
1034
7709
1.73
30.04
5.1
3.7
estimate
0.0
0.0
1.08
227
1354
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
133
457
3.05
29.64
1.5
1.6
iu/ml
0.7
0.1
0.44
29
74
(3023368) Bacteria identified in Blood by Culture
669
4454
1.76
28.85
4.9
4.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1020
7628
1.71
28.85
6.6
5.0
estimate
0.0
0.0
0.50
236
1408
(3044889) 12 lead EKG panel
1415
11606
1.80
28.46
4.6
3.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
648
4295
1.76
28.26
2.8
2.7
umol/l
3014.0
6271.7
1.56
566
3737
(3018418) pH of Serum or Plasma
713
4867
1.73
27.94
4.3
4.3
ph
7.4
7.4
0.75
165
954
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
419
2439
1.91
27.85
1.3
1.3
u/ml
21.3
12.3
0.94
140
957
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
744
5159
1.71
27.41
3.8
3.2
u/l
33.6
35.1
0.26
701
4904
(3002385) Erythrocyte distribution width [Ratio]
1545
13069
1.87
27.40
27.3
17.9
%
14.0
13.7
10.38
1531
12758
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
128
451
2.97
27.28
1.9
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
430
2544
1.89
27.11
1.4
1.3
iu/ml
46.0
39.5
0.36
167
819
(3021589) Normoblasts [#/volume] in Blood
946
7027
1.67
26.67
14.5
9.7
e9/l
0.0
0.0
0.97
814
5717
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1059
8171
1.65
25.16
7.3
7.3
mmol/l
1.2
1.2
0.07
871
6845
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
889
6571
1.65
25.00
2.5
2.2
nmol/l
76.5
78.0
0.94
823
5865
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1091
8499
1.64
24.80
5.7
6.6
umol/l
11.5
11.7
0.12
1050
8088
(3037522) Nuclear Ab [Titer] in Serum
356
2038
1.91
24.60
1.4
1.3
titre
370.7
531.9
1.15
71
441
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
980
7443
1.64
24.58
6.5
6.4
mmol/l
1.2
1.2
0.25
911
6717
(3022948) Iron [Moles/volume] in Serum or Plasma
410
2484
1.82
23.60
2.7
2.6
umol/l
12.2
13.1
1.94
376
2307
(3004789) Transferrin [Mass/volume] in Serum or Plasma
387
2308
1.84
23.43
2.7
2.6
g/l
2.3
2.3
0.27
359
2151
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
368
2174
1.85
22.92
2.8
2.7
%
22.4
23.0
0.27
286
1873
(3047181) Lactate [Moles/volume] in Blood
129
503
2.68
22.72
6.0
7.4
mmol/l
1.3
1.3
0.02
117
430
(3001122) Ferritin [Mass/volume] in Serum or Plasma
848
6326
1.60
22.08
3.2
2.8
ug/l
142.4
147.8
0.26
785
5826
(3015736) pH of Urine
803
5918
1.61
21.96
4.7
3.4
—
5.9
—
0
6
(3039000) Anion gap in Blood
103
364
2.93
21.83
6.2
8.7
mmol/l
10.9
11.2
0.29
95
317
(3018572) Chloride [Moles/volume] in Blood
103
364
2.93
21.83
6.2
8.7
mmol/l
105.6
105.4
0.13
95
317
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
574
3911
1.66
21.44
2.5
2.2
mg/l
2.8
3.0
1.86
506
3297
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
189
907
2.20
21.03
8.5
11.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
682
4881
1.61
20.78
2.6
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
511
3409
1.68
20.56
6.7
4.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
501
3331
1.68
20.40
1.8
1.8
mg/l
1.3
1.3
0.15
418
2556
(40761536) Microorganisms panel - Urine sediment
242
1313
1.96
19.33
5.3
3.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1818
16719
2.27
19.22
23.0
16.8
mmol/l
139.4
139.7
3.91
1799
16256
(3017181) Myelocytes/100 leukocytes in Blood
248
1360
1.94
19.20
4.2
4.4
%
0.6
0.9
1.65
59
428
(3026008) Bacteria identified in Urine by Culture
654
4706
1.59
19.11
3.7
3.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
283
1627
1.86
18.96
7.6
9.0
g/l
120.1
121.3
0.40
270
1561
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
411
2641
1.70
18.82
2.0
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
311
1845
1.82
18.82
2.0
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
232
1255
1.96
18.67
3.9
4.1
%
0.4
0.6
1.60
45
311
(3025159) Blasts/100 leukocytes in Blood
226
1216
1.97
18.47
4.4
4.4
%
0.1
0.3
0.40
52
329
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
476
3203
1.64
18.20
4.3
3.7
ng/l
166.4
452.9
3.93
389
2538
(3023103) Potassium [Moles/volume] in Serum or Plasma
1818
16773
2.22
18.15
23.3
17.0
mmol/l
4.0
4.0
1.64
1799
16284
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
306
1838
1.79
17.70
2.1
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
300
1799
1.79
17.43
1.9
1.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
292
1744
1.79
17.18
7.3
8.5
%
96.2
95.5
1.68
278
1681
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
771
5861
1.52
17.14
5.4
3.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
570
4068
1.57
16.83
4.2
3.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1671
15068
1.76
16.80
6.5
5.8
mmol/mol
39.8
40.1
0.89
1567
13852
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
848
6602
1.50
16.68
2.1
2.0
pmol/l
94.7
94.5
0.05
457
3392
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
213
1166
1.93
16.49
1.7
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
609
4428
1.55
16.49
1.8
1.6
mmol/l
1.4
1.4
0.21
496
3695
(3026470) Cobalt [Mass/volume] in Blood
38
84
4.59
16.13
2.0
2.0
ug/l
3.1
2.7
0.17
30
73
(3000850) Epithelial cells [#/volume] in Urine
481
3340
1.58
15.85
2.9
2.6
e6/l
5.3
5.5
0.12
425
2931
(3021440) Promyelocytes/100 leukocytes in Blood
228
1294
1.86
15.78
4.4
4.4
%
0.1
0.1
0.44
56
392
(3021960) Folate [Moles/volume] in Serum or Plasma
524
3716
1.56
15.73
1.7
1.5
nmol/l
20.9
20.8
0.05
466
3150
(3005719) IgG [Mass/volume] in Serum or Plasma
220
1236
1.88
15.72
2.8
3.0
g/l
10.3
10.4
0.14
204
1131
(3025577) Chromium [Mass/volume] in Blood
37
82
4.58
15.66
2.4
2.0
ug/l
2.4
1.8
0.60
32
70
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
667
4989
1.51
15.65
2.3
2.1
u/l
216.9
224.5
0.07
629
4680
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
312
1950
1.71
15.57
7.4
8.1
kpa
5.1
5.1
0.09
298
1855
(3027801) Oxygen [Partial pressure] in Arterial blood
312
1951
1.71
15.54
7.4
8.1
kpa
12.5
12.2
0.55
299
1858
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
26
42
6.26
15.48
1.8
1.8
mg/l
8.5
8.8
0.08
17
33
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
671
5050
1.50
15.18
2.5
2.6
u/l
55.0
58.4
0.48
615
4666
(3003396) Base excess in Arterial blood by calculation
309
1944
1.70
15.02
7.4
8.1
mmol/l
1.2
1.1
0.26
249
1531
(3024263) Appearance of Synovial fluid
32
66
4.91
14.75
4.3
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
236
1382
1.80
14.73
4.0
2.9
ng/l
172.3
207.7
1.00
221
1258
(3021879) Hepatitis B virus core Ab [Presence] in Serum
184
1000
1.93
14.52
1.3
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
594
4402
1.50
14.30
3.6
3.1
e6/l
0.5
0.5
0.02
467
3333
(3000494) Fungus identified in Specimen by Culture
300
1896
1.69
14.29
1.5
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
581
4292
1.50
14.18
3.5
3.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
251
1514
1.75
14.15
1.5
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
137
683
2.08
13.78
5.5
6.0
%
1.8
1.6
1.73
127
631
(3008152) Bicarbonate [Moles/volume] in Arterial blood
189
1056
1.87
13.70
7.5
7.3
mmol/l
24.6
24.5
0.13
175
983
(3018095) Leukocytes [#/volume] in Urine
718
5565
1.46
13.64
4.5
3.7
e6/l
126.8
117.6
0.10
530
3969
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
269
1671
1.71
13.63
1.4
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1778
16533
1.85
13.40
21.2
13.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
550
4072
1.49
13.09
7.7
6.9
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
133
673
2.05
12.86
5.6
6.0
%
1.0
0.9
2.92
124
624
(3029937) Albumin [Presence] in Urine by Test strip
555
4130
1.48
12.84
6.0
4.0
estimate
0.0
0.0
0.80
231
1347
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
508
3753
1.48
12.06
2.6
2.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
622
4798
1.43
11.71
3.7
3.2
e6/l
84.6
78.6
0.08
497
3694
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
618
4770
1.43
11.56
3.0
3.1
ng/l
1821.2
1394.2
0.72
533
4088
(3019060) Gas panel - Arterial blood
189
1123
1.76
11.17
5.0
5.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1574
14362
1.50
10.89
25.5
15.7
%
39.5
39.8
0.44
1029
10050
(3036481) Cortisol [Moles/volume] in Serum or Plasma
230
1454
1.66
10.82
2.2
2.3
nmol/l
366.8
377.5
0.34
211
1325
(3026782) Osmolality of Urine
430
3136
1.48
10.73
3.1
2.8
mosm/kgh2o
532.1
547.4
0.73
372
2673
(46235355) HIV 1 and 2 tests - Meaningful Use set
293
1971
1.57
10.68
1.5
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1199
10440
1.38
10.65
3.4
3.1
u/l
57.5
52.6
0.96
1125
9653
(3009445) Proteinase 3 Ab [Units/volume] in Serum
126
671
1.94
10.56
1.7
1.5
u/ml
15.5
23.9
—
6
17
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1056
9026
1.37
10.41
2.9
2.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1813
17140
1.81
10.39
16.7
10.7
u/l
27.9
26.4
0.92
1771
16501
(3009508) Creatinine [Moles/volume] in Urine
652
5179
1.39
10.04
3.1
3.1
mmol/l
7.4
7.5
0.15
550
4359
(3027945) Reticulocytes/100 erythrocytes in Blood
277
1874
1.56
9.81
2.4
2.7
%
2.0
1.8
2.29
248
1673
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
279
1894
1.55
9.73
3.7
4.5
u/l
232.9
249.0
1.45
267
1797
(3020630) Protein [Mass/volume] in Serum or Plasma
219
1412
1.62
9.51
2.1
3.0
g/l
65.8
66.5
0.55
207
1289
(3011397) Hemoglobin [Presence] in Urine by Test strip
477
3619
1.42
9.50
5.5
3.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
271
1838
1.55
9.48
2.7
2.8
umol/l
7.7
8.4
0.27
241
1610
(3037756) Immunofixation for Serum or Plasma
79
371
2.18
9.33
1.3
1.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1578
14526
1.45
9.31
5.1
4.7
mu/l
1.9
2.2
1.04
1450
13194
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
760
6245
1.36
9.28
4.2
3.6
ng/l
608.6
52.9
0.47
543
4400
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
82
392
2.14
9.26
1.2
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
626
5003
1.37
9.09
3.1
3.2
mg/l
484.4
356.4
0.25
407
3142
(3020682) Albumin/Creatinine [Ratio] in Urine
654
5267
1.36
9.03
4.0
3.9
mg/mmol
9.8
8.6
0.22
423
3329
(3028026) IgM [Mass/volume] in Serum or Plasma
161
972
1.72
8.99
1.5
1.9
g/l
1.1
1.4
1.28
146
894
(3023520) Reticulocytes [#/volume] in Blood
216
1407
1.60
8.98
2.9
2.7
e9/l
78.6
70.4
1.60
152
1075
(3004588) Protein electrophoresis panel - Serum or Plasma
185
1166
1.65
8.79
1.9
2.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
308
2181
1.49
8.77
5.5
6.4
mmol/l
1.1
1.0
0.88
295
2018
(3015171) Extractable nuclear Ab [Units/volume] in Serum
106
571
1.91
8.63
1.4
1.2
u/ml
0.3
1.0
—
6
54
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
212
1392
1.59
8.52
3.9
4.0
mmol/l
1.2
1.2
0.20
188
1211
(3010813) Leukocytes [#/volume] in Blood
1851
17730
1.85
8.43
32.9
21.4
e9/l
7.0
6.7
3.61
1815
17160
(3007461) Platelets [#/volume] in Blood
1850
17719
1.84
8.41
32.9
21.4
e9/l
253.5
248.9
2.14
1813
17203
(3024731) MCV [Entitic volume]
1850
17722
1.84
8.36
32.8
21.3
fl
91.8
91.4
4.41
1835
17419
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
52
214
2.47
8.34
1.5
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
685
5610
1.34
8.31
2.7
3.6
mmol/l
2.3
2.4
0.74
614
4933
(3035941) MCH [Entitic mass]
1850
17725
1.84
8.31
32.8
21.2
pg
30.5
30.4
0.73
1835
17420
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
195
1263
1.60
8.30
2.4
2.7
ml/min/173m2
61.2
64.5
0.41
82
501
(3026361) Erythrocytes [#/volume] in Blood
1850
17726
1.84
8.30
32.9
21.3
e12/l
4.4
4.5
10.50
1814
17156
(3012095) Magnesium [Moles/volume] in Serum or Plasma
371
2750
1.43
8.29
3.2
3.5
mmol/l
0.8
0.8
0.30
354
2585
(3006184) Hemoglobin [Mass/volume] in Capillary blood
73
349
2.13
8.28
2.3
2.2
g/l
125.6
128.2
0.40
52
258
(3000963) Hemoglobin [Mass/volume] in Blood
1850
17732
1.83
8.20
33.1
21.5
g/l
133.1
135.7
10.82
1835
17423
(40768797) Stomach Pathology biopsy report
312
2252
1.46
8.02
1.3
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
57
261
2.22
7.23
1.4
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1326
12037
1.32
7.22
4.3
4.0
pmol/l
14.9
14.9
0.18
1206
10894
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
445
3476
1.36
7.20
1.8
1.7
pmol/l
98365541.3
26528209.5
0.93
367
2880
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
63
301
2.13
7.20
1.4
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
53
236
2.28
7.18
1.4
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
71
357
2.03
7.09
3.0
2.6
%
15.8
16.0
0.22
34
184
(3019309) Folate [Moles/volume] in Red Blood Cells
391
2999
1.38
7.08
2.0
1.8
nmol/l
1298.6
1188.6
1.19
306
2279
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
57
264
2.19
7.04
1.2
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
84
453
1.89
6.87
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
46
197
2.37
6.83
1.4
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
30
104
2.91
6.75
1.9
2.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
423
3309
1.36
6.73
6.2
4.1
kg/l
1.0
1.0
0.40
61
454
(3036071) Salmonella sp Ab [Titer] in Serum
19
49
3.91
6.71
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1696
16057
1.43
6.51
4.9
4.5
mmol/l
4.6
4.7
1.78
1568
14796
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
124
764
1.67
6.47
1.5
1.8
g/l
1.7
1.6
1.34
103
659
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
284
2095
1.42
6.43
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
235
1674
1.46
6.43
2.1
2.2
ug/g
204.0
147.6
0.79
180
1353
(3017732) Neutrophils [#/volume] in Blood
159
1046
1.57
6.35
4.2
3.3
e9/l
4.1
4.1
0.13
139
803
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1683
15940
1.41
6.19
4.9
4.5
mmol/l
1.4
1.5
1.09
1548
14596
(3018677) aPTT in Platelet poor plasma by Coagulation assay
335
2563
1.37
6.10
2.1
2.1
s
30.2
29.8
0.51
324
2489
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
115
706
1.67
6.10
2.1
2.0
ug/l
0.9
1.3
0.80
100
631
(3034860) Kappa light chains.free [Mass/volume] in Serum
95
554
1.75
6.07
2.1
4.1
mg/l
64.1
59.0
0.11
69
452
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
95
555
1.75
6.03
2.0
4.1
mg/l
47.7
63.1
0.36
70
455
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
75
412
1.85
5.84
1.4
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
52
252
2.09
5.79
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
348
2716
1.34
5.54
2.9
2.7
e6/l
1.2
1.1
0.02
200
1544
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
63
333
1.92
5.53
1.2
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
72
398
1.84
5.52
1.4
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1718
16391
1.40
5.48
5.5
5.0
mmol/l
2.7
2.8
4.02
1591
15023
(3012501) Base excess in Blood by calculation
70
386
1.84
5.41
4.7
4.6
mmol/l
2.4
2.6
0.15
49
271
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
112
2.61
5.39
1.5
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1661
15771
1.36
5.38
5.0
4.6
mmol/l
6.0
6.0
0.33
1526
14307
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
26
96
2.73
5.27
1.4
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
26
96
2.73
5.27
1.4
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
500
4130
1.28
5.24
4.7
4.0
%
89.5
89.3
0.05
489
4034
(3052851) Hemolysis interference index of Serum or Plasma
84
496
1.72
5.18
3.4
3.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
76
436
1.77
5.18
1.9
1.6
g/l
0.2
0.2
0.05
70
416
(3000991) Gas panel - Venous blood
198
1423
1.44
5.18
8.4
9.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
46
226
2.06
4.98
1.3
1.2
u/ml
1.4
4.2
1.27
19
75
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
79
465
1.73
4.94
1.8
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
241
2.02
4.91
1.4
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
45
221
2.06
4.89
1.1
1.1
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
16
47
3.42
4.75
2.1
2.4
%
27.5
29.7
0.22
16
40
(40760888) Immunoglobulin light chains.free panel - Serum
71
415
1.74
4.57
1.4
4.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
76
453
1.71
4.57
1.8
1.5
g/l
1.2
1.2
0.35
69
433
(3022145) Colonoscopy Study observation
238
1810
1.36
4.47
1.3
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
135
931
1.48
4.40
1.3
1.3
u/ml
121.6
202.3
2.67
128
852
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
25
100
2.52
4.38
2.0
3.0
%
43.7
38.8
0.49
13
31
(1616796) Gas panel - Central venous blood
65
377
1.75
4.32
4.0
3.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
216
1627
1.37
4.32
1.9
2.1
g/l
0.2
0.2
0.22
202
1524
(3007164) IgA [Mass/volume] in Serum or Plasma
352
2851
1.29
4.23
1.3
1.5
g/l
2.7
2.5
0.67
223
1741
(4306422)
42
213
1.99
4.22
1.1
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
27
115
2.37
4.16
2.0
2.1
%
15.1
13.9
0.18
15
40
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
78
481
1.65
4.16
1.3
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
32
147
2.20
4.15
1.9
2.2
e9/l
1.4
1.1
0.58
26
88
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
90
576
1.59
4.13
2.8
2.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
91
585
1.58
4.10
1.7
2.4
ug/l
437.7
811.2
0.49
86
549
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
30
135
2.24
4.09
1.4
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
70
422
1.68
4.07
2.4
3.3
mmol/l
24.8
25.0
0.11
61
373
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1616
15423
1.28
4.02
4.3
4.0
mmol/l
1.4
1.3
3.69
1477
14044
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
60
348
1.75
4.01
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
60
348
1.75
4.01
1.2
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
121
833
1.48
4.00
1.3
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
33
157
2.12
3.95
2.7
2.9
mg/l
7.8
40.5
1.99
23
120
(44790049)
38
191
2.01
3.94
1.3
1.5
—
—
—
0
0
(44790048)
38
191
2.01
3.94
1.3
1.5
—
—
—
0
0
(44806118)
38
191
2.01
3.94
1.3
1.5
—
—
—
0
0
(44790047)
38
191
2.01
3.94
1.3
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
42
219
1.94
3.93
1.2
1.2
u/ml
2.7
5.9
1.23
24
99
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
314
2532
1.29
3.90
3.1
2.9
e6/l
3.4
2.2
0.95
166
1365
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
27
119
2.29
3.88
1.0
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
93
613
1.54
3.79
2.4
2.9
g/l
10.1
10.3
0.10
83
522
(3023419) Bacteria identified in Sputum by Culture
41
215
1.93
3.78
1.8
2.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
26
114
2.30
3.78
1.2
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
87
568
1.56
3.70
2.5
2.9
g/l
0.8
1.3
0.87
80
498
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
50
282
1.79
3.70
2.8
3.6
—
—
—
0
0
(4268621)
31
148
2.11
3.69
2.2
2.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
93
620
1.53
3.61
2.5
3.0
g/l
3.3
3.1
1.74
80
492
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
50
285
1.77
3.58
1.6
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
654
1.51
3.58
2.4
2.9
g/l
7.6
7.4
0.76
80
500
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
654
1.51
3.58
2.4
2.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
654
1.51
3.58
2.4
2.9
g/l
4.2
3.7
1.71
79
481
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
169
1270
1.36
3.46
4.1
4.0
ng/l
82.4
94.0
1.30
148
1099
(3028626) Oxygen [Partial pressure] in Capillary blood
61
373
1.66
3.41
2.7
2.9
kpa
8.1
8.0
0.19
55
346
(4010399)
156
1161
1.37
3.40
1.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
54
320
1.71
3.40
2.7
2.9
—
—
—
0
0
(3013512) EKG study
557
4853
1.21
3.39
4.2
3.9
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
36
190
1.91
3.30
1.4
1.4
mu/l
53.1
57.6
0.09
36
167
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
81
536
1.53
3.28
1.7
1.6
titre
95.0
306.0
—
8
30
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
378
3180
1.23
3.25
1.2
1.2
u/ml
2.4
1.4
0.41
94
829
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
43
243
1.79
3.20
1.4
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
11
33
3.35
3.19
3.5
2.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
138
1019
1.38
3.17
2.9
3.7
kpa
5.2
5.2
0.66
127
949
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
26
124
2.11
3.14
1.0
1.1
titre
60.0
128.0
—
6
20
(3009343) pH of Capillary blood
136
1004
1.38
3.13
2.9
3.7
ph
7.4
7.4
0.10
29
134
(3014111) Lactate [Moles/volume] in Serum or Plasma
194
1514
1.31
3.10
7.7
7.6
mmol/l
1.3
1.4
0.37
189
1463
(3017704) Immunofixation for Urine
23
105
2.20
3.09
1.2
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
59
368
1.62
3.09
1.7
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
134
992
1.38
3.04
3.7
3.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
84
572
1.49
3.00
2.7
3.1
u/ml
0.4
0.3
0.13
56
324
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
40
3.01
2.97
1.3
1.8
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
18
75
2.41
2.97
1.1
1.3
umol/l
17.5
25.6
0.64
18
70
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1591
15293
1.22
2.89
19.6
13.6
ml/min/173m2
80.6
78.9
2.55
1359
12619
(3009871) Measles virus Ab [Titer] in Serum
15
58
2.60
2.87
1.7
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
27
136
2.00
2.85
1.5
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
130
969
1.37
2.84
2.8
3.7
mmol/l
2.8
1.8
2.22
93
721
(3024980) IgG subclass 4 [Mass/volume] in Serum
41
238
1.74
2.82
1.7
1.8
g/l
0.9
0.8
0.07
27
183
(3022217) INR in Platelet poor plasma by Coagulation assay
258
2114
1.25
2.82
23.8
24.9
inr
1.4
1.3
0.21
39
269
(3014576) Chloride [Moles/volume] in Serum or Plasma
263
2164
1.25
2.77
7.9
7.3
mmol/l
104.5
104.2
0.59
253
2111
(3045414) Leukocytes [Presence] in Urine
96
683
1.43
2.76
2.1
1.8
—
—
—
0
0
(4062490)
28
145
1.94
2.75
1.2
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
225
1820
1.27
2.74
1.6
1.8
%
1.5
1.5
0.17
188
1589
(3034426) Prothrombin time (PT)
13
48
2.72
2.72
1.1
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
33
182
1.83
2.70
1.1
1.3
nmol/l
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
18
79
2.29
2.67
1.3
1.3
nmol/l
1.1
1.2
0.35
12
60
(3020650) Glucose [Presence] in Urine
12
43
2.80
2.64
1.8
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
54
345
1.58
2.61
3.4
5.9
iu/ml
1548.8
775.8
—
6
50
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
112
829
1.37
2.58
2.6
2.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
122
917
1.35
2.56
2.9
3.4
pmol/l
4.6
4.4
0.52
113
808
(3027135) IgG subclass 1 [Mass/volume] in Serum
27
142
1.91
2.56
1.2
1.5
g/l
5.8
7.1
1.26
15
96
(3028192) IgG subclass 2 [Mass/volume] in Serum
27
142
1.91
2.56
1.2
1.5
g/l
3.7
3.0
0.42
15
96
(3024139) IgG subclass 3 [Mass/volume] in Serum
27
142
1.91
2.56
1.2
1.5
g/l
0.3
0.4
0.72
15
96
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
16
68
2.36
2.55
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
33
186
1.79
2.53
1.6
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
57
372
1.55
2.52
1.1
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
359
3081
1.20
2.52
2.9
3.2
mmol/l
2.5
2.5
0.26
317
2723
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
57
373
1.54
2.50
1.4
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
469
4126
1.18
2.48
1.5
1.3
—
—
—
0
0
(3036489) Thrombin time
84
597
1.43
2.46
2.9
2.0
s
20.9
21.8
1.12
74
532
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
48
303
1.60
2.45
1.5
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
95
1287
0.72
2.45
1.2
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
43
265
1.64
2.42
1.7
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
33
189
1.76
2.42
1.5
1.7
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
10
34
2.95
2.41
1.1
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
38
227
1.69
2.40
2.1
2.5
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
8
6.26
2.37
1.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
32
183
1.76
2.36
7.1
6.4
mmol/l
7.9
7.7
0.09
26
155
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
65
444
1.48
2.35
3.4
2.9
mg/l
1.6
1.6
0.18
56
408
(3016650) Hepatitis A virus Ab [Presence] in Serum
40
245
1.65
2.32
1.2
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
61
413
1.49
2.31
2.3
2.0
mg/l
10.8
12.1
0.57
61
379
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
59
397
1.50
2.30
1.3
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
199
1623
1.25
2.29
1.6
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
130
1005
1.31
2.28
1.7
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
646
5865
1.15
2.25
5.0
4.8
ug/l
2.0
2.8
2.77
579
5228
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
9
5.57
2.21
1.0
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
106
800
1.34
2.20
4.7
3.9
mmol/l
24.5
24.1
0.61
97
719
(3013293) Extractable nuclear Ab [Presence] in Serum
8
24
3.34
2.18
1.5
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
24
3.34
2.18
1.3
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
137
1075
1.30
2.17
2.3
2.4
au/ml
33.3
23.6
—
7
51
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
19
94
2.03
2.16
2.2
2.4
e9/l
0.2
0.2
0.07
19
82
(3027456) Digoxin [Moles/volume] in Serum or Plasma
51
339
1.52
2.13
3.4
3.1
nmol/l
0.9
0.8
0.36
44
262
(3004451) EKG impression Narrative
18
88
2.06
2.11
1.2
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
192
1576
1.24
2.10
4.2
3.7
mmol/l
2.4
1.9
1.12
161
1278
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
90
672
1.36
2.02
2.2
1.9
u/l
36.5
38.8
0.50
76
595
(3021447) Carbon dioxide [Partial pressure] in Venous blood
192
1584
1.24
2.02
4.2
3.7
kpa
5.9
5.8
0.45
183
1533
(3007566) Smooth muscle Ab [Titer] in Serum
62
437
1.43
1.96
1.1
1.1
titre
168.0
89.7
—
5
31
(3000570) Elastase.pancreatic [Mass/mass] in Stool
68
488
1.41
1.95
1.5
1.5
ug/g
321.1
272.4
1.03
36
301
(3001019) Free T4 and TSH panel - Serum or Plasma
49
712
0.68
1.94
1.8
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
104
1335
0.77
1.90
2.0
1.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
18
92
1.97
1.90
4.1
6.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
23
128
1.81
1.90
1.3
1.2
u/ml
1.5
0.3
0.46
13
63
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
184
1527
1.23
1.85
2.6
2.5
u/l
424.2
41.5
0.50
157
1330
(40761535) Cells panel - Urine sediment
165
1355
1.24
1.83
4.7
3.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
67
486
1.39
1.82
2.0
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
16
80
2.01
1.80
1.1
1.2
nmol/l
142.3
141.3
0.02
16
80
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
41
271
1.52
1.79
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
30
184
1.64
1.79
1.3
2.4
—
—
—
0
0
(3000492) Spirometry study
179
1487
1.22
1.79
1.4
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
21
116
1.82
1.78
1.2
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
97
749
1.31
1.77
1.6
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
13
3.85
1.71
2.0
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
63
458
1.39
1.71
1.2
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
33
211
1.57
1.68
1.1
1.3
nmol/l
0.6
0.7
1.78
33
201
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
55
2.19
1.67
1.8
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
63
461
1.38
1.65
1.2
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
17
90
1.90
1.65
5.2
3.0
ph
7.4
7.4
—
8
32
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
25
2.81
1.65
1.0
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
60
436
1.39
1.64
6.6
2.4
%
193.1
198.8
0.15
55
416
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
49
2.25
1.63
1.0
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
29
182
1.60
1.60
1.3
1.2
mmol/l
7.5
7.5
0.00
20
135
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
10
43
2.33
1.60
1.8
1.2
%
103.5
101.1
—
10
37
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
51
363
1.42
1.58
1.6
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
24
144
1.67
1.57
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
62
457
1.37
1.57
1.2
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
78
1.93
1.54
1.7
2.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
44
2.28
1.53
1.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
40
274
1.47
1.52
1.2
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
515
4716
1.13
1.51
4.6
4.2
%
20.8
21.7
0.74
237
2334
(40768795) Lymph node Pathology biopsy report
26
162
1.61
1.49
1.1
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
14
72
1.95
1.49
2.6
3.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
177
1501
1.20
1.47
7.4
8.2
mmol/l
10.7
9.9
0.83
172
1427
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
42
293
1.44
1.46
1.4
1.2
u/ml
20.9
46.5
—
7
29
(3042111) Morphology [Interpretation] in Bone marrow Narrative
44
310
1.43
1.46
1.6
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
43
302
1.43
1.45
1.4
1.4
mmol/l
58.4
60.8
0.23
37
242
(40768804) Tissue Pathology biopsy report
701
6545
1.11
1.44
2.1
2.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
24
148
1.63
1.44
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
23
361
0.63
1.39
2.4
3.7
mg/l
36.8
26.5
0.63
12
228
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
23
142
1.63
1.38
1.5
1.6
—
—
—
0
0
(4211845)
13
67
1.95
1.38
4.1
3.7
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
17
2.95
1.36
34.4
16.9
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
22
135
1.64
1.36
3.7
4.9
u/ml
49.8
70.6
—
5
36
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
17
97
1.76
1.35
1.5
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
47
2.13
1.33
1.4
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
242
2126
1.16
1.33
1.3
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
201
1.50
1.30
1.2
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
14
76
1.85
1.30
2.4
2.4
%
109.3
100.0
0.37
14
70
(3003327) Ova and parasites identified in Stool by Light microscopy
60
457
1.32
1.28
1.6
1.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
17
99
1.72
1.27
1.5
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
116
960
1.22
1.26
1.4
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
19
2.64
1.21
1.2
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
53
400
1.33
1.21
1.1
1.2
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
8
38
2.11
1.18
1.0
1.3
nmol/l
178.2
134.5
—
8
32
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
20
125
1.61
1.17
2.4
1.4
u/ml
29.8
21.7
—
8
24
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
20
2.50
1.15
1.2
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
46
343
1.35
1.15
2.3
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
132
1120
1.19
1.14
1.1
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
31
216
1.44
1.13
1.4
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
40
2.00
1.12
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
40
2.00
1.12
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
40
2.00
1.12
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
40
2.00
1.12
1.0
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
268
1.39
1.11
1.8
2.7
u/ml
2979.4
1451.5
—
5
19
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
21
2.38
1.09
1.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
14
81
1.73
1.09
4.4
2.6
mmol/l
8.4
9.7
—
5
61
(3022689) Creatine [Moles/volume] in Urine
8
41
1.96
1.09
1.9
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
30
419
0.71
1.06
4.4
4.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
30
211
1.43
1.06
1.0
1.1
u/ml
0.4
1.9
1.41
12
78
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
33
2.13
1.05
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
12
67
1.80
1.04
1.1
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
60
1.84
1.03
1.0
1.1
miu/ml
1694.9
1605.0
0.10
11
60
(3051611) Lipemic interference index of Serum or Plasma
25
171
1.47
1.02
3.6
3.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
68
546
1.25
1.02
1.5
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
51
395
1.30
1.01
3.4
2.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
28
197
1.43
1.00
1.2
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
35
2.00
1.00
1.0
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
25
172
1.46
1.00
1.2
1.2
u/l
40.3
56.1
2.06
18
126
(3004775) Volume in Urine collected for unspecified duration
20
131
1.53
1.00
2.0
2.3
ml
698.6
654.1
0.13
11
85
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
17
107
1.59
0.99
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
107
1.59
0.99
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
107
1.59
0.99
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
11
61
1.81
0.98
4.6
3.9
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
36
1.95
0.97
1.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
27
190
1.43
0.97
1.2
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
27
190
1.43
0.97
1.2
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
54
1.86
0.96
1.0
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
12
69
1.74
0.96
1.1
1.2
%
—
84.6
—
0
7
(21494814) CD8 cells/100 lymphocytes in Specimen
12
69
1.74
0.96
1.8
1.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
77
1.69
0.95
1.2
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
27
191
1.42
0.94
1.2
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
14
85
1.65
0.94
1.3
1.2
ratio
1.1
1.1
—
6
31
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
28
200
1.41
0.93
1.1
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
17
109
1.56
0.93
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
17
109
1.56
0.93
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
17
109
1.56
0.93
1.1
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
120
0.50
0.93
1.5
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
13
78
1.67
0.91
1.2
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
63
1.75
0.90
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
136
1185
1.16
0.89
2.5
2.1
nmol/l
12.8
13.1
0.15
117
1050
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
29
2.07
0.89
1.5
2.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
135
1.49
0.89
1.5
2.1
u/field
1.1
2.4
—
7
57
(3017817) Protein [Mass] in Urine collected for unspecified duration
22
152
1.45
0.88
1.7
2.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
101
862
1.18
0.86
1.7
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
83
697
1.20
0.85
1.1
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
45
1.78
0.84
1.3
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
115
0.52
0.82
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
115
0.52
0.82
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
115
0.52
0.82
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
115
0.52
0.82
1.3
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
46
1.74
0.82
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
23
163
1.42
0.82
1.0
1.1
u/ml
1.0
2.8
—
6
37
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
16
105
1.53
0.81
1.6
1.6
u/l
5.9
5.7
—
10
58
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
81
1.61
0.81
1.6
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
13
81
1.61
0.81
1.6
1.6
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
16
106
1.51
0.79
1.7
1.4
u/l
12.6
13.6
0.18
16
100
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
24
173
1.39
0.79
2.4
4.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
66
1.67
0.78
1.1
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
74
1.63
0.78
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
23
165
1.40
0.77
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
34
1.77
0.76
5.8
7.8
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
24
2.09
0.74
1.4
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
24
2.09
0.74
2.0
1.9
mmol/l
1.2
1.2
—
5
24
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
25
2.00
0.72
1.6
1.3
ng/l
150.7
129.3
—
5
25
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
39
1.80
0.72
1.0
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
40
317
1.27
0.72
1.2
1.3
u/l
10.3
10.5
0.03
31
256
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
10
60
1.67
0.72
1.4
1.9
ug/l
24.5
17.7
—
10
52
(3022493) Free Hemoglobin [Mass/volume] in Plasma
11
68
1.62
0.71
1.0
8.4
mg/l
67.7
68.1
—
6
47
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
73
858
0.85
0.71
1.6
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
26
194
1.34
0.71
1.2
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
85
731
1.17
0.70
2.8
3.8
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
27
1.85
0.68
3.6
5.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
117
0.60
0.68
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
26
196
1.33
0.67
1.2
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
92
0.54
0.67
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
14
94
1.49
0.66
2.5
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
28
1.79
0.66
1.0
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
56
467
1.21
0.66
1.4
1.3
iu/l
25.8
33.3
1.32
51
397
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
70
1.57
0.65
1.3
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
19
259
0.73
0.65
1.1
1.1
iu/ml
1.0
55.6
—
6
50
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
120
1.42
0.64
1.0
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
145
1305
1.12
0.64
3.8
2.9
kpa
4.3
4.6
1.08
138
1262
(3004809) Band form neutrophils/100 leukocytes in Blood
35
279
1.26
0.62
3.1
3.7
%
0.5
1.3
3.34
28
225
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
104
1.45
0.62
1.3
1.2
mmol/l
11.4
12.2
—
6
35
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
103
0.58
0.62
1.5
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
30
1.67
0.61
1.0
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
96
1.46
0.61
1.4
1.7
—
—
—
0
0
(4015189)
8
50
1.60
0.61
2.6
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
50
1.60
0.61
8.9
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
50
1.60
0.61
8.9
2.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
26
200
1.30
0.60
1.3
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
188
2047
0.91
0.60
8.6
6.9
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
35
1.72
0.57
1.2
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
25
193
1.30
0.57
1.4
2.5
mg/l
21.0
20.0
—
9
54
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
118
1058
1.12
0.57
1.2
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
12
81
1.48
0.57
1.1
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
81
1.48
0.57
1.8
2.7
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
12
81
1.48
0.57
39.3
25.7
ug/l
94.9
119.1
0.76
12
66
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
12
81
1.48
0.57
1.3
1.1
u/l
22.2
19.3
0.12
12
58
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
12
81
1.48
0.57
1.3
1.1
u/l
69.3
75.0
0.20
12
62
(3013005) Retinol [Moles/volume] in Serum or Plasma
8
55
1.46
0.56
1.1
1.6
umol/l
1.9
1.9
—
8
49
(3011648) Oxygen content in Venous blood
10
148
0.67
0.55
2.5
1.9
%
10.0
11.2
—
10
148
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
24
305
0.78
0.53
2.4
3.9
u/ml
28.2
33.9
0.19
24
300
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
39
1.54
0.53
1.2
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
23
178
1.30
0.53
1.3
1.3
mosm/kgh2o
275.7
276.4
0.05
16
137
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
24
187
1.29
0.52
1.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
13
181
0.72
0.52
1.2
1.9
—
1504.0
—
0
5
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
10
66
1.52
0.52
2.9
1.8
umol/l
570.8
115.3
—
5
35
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
98
0.61
0.52
1.2
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
43
360
1.20
0.52
1.6
1.5
mu/l
378.4
294.4
0.73
36
330
(3005033) Fetal Nuchal fold Thickness US
6
99
0.60
0.52
1.3
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
99
0.60
0.52
1.3
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
157
0.70
0.51
1.0
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
25
197
1.27
0.51
1.4
2.1
u/l
473.8
2558.0
—
6
73
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
21
162
1.30
0.50
1.8
2.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
23
180
1.28
0.49
1.3
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
30
243
1.24
0.49
1.1
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
45
1.56
0.49
7.1
6.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
24
190
1.27
0.48
1.0
1.1
u/ml
2.6
4.1
0.50
14
82
(3043410) Blood group antigens tested for on Red Blood Cells
7
48
1.46
0.46
1.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
71
627
1.14
0.46
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
24
191
1.26
0.46
1.3
1.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
49
1.43
0.46
7.3
6.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
198
0.76
0.45
2.3
1.6
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
10
141
0.71
0.44
1.3
1.1
—
61.8
—
0
13
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
37
312
1.19
0.43
2.4
1.9
pmol/l
196.1
205.5
0.28
30
297
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
10
140
0.71
0.43
1.3
1.1
—
46.9
—
0
7
(1761868) Lipid panel - Serum or Plasma
590
5706
1.05
0.43
3.3
2.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
117
1070
1.10
0.43
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
77
688
1.12
0.43
1.3
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
193
2062
0.93
0.43
5.2
4.5
%
32.3
32.7
0.20
141
1356
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
56
1.43
0.42
5.0
2.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
10
70
1.43
0.41
9.1
13.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.0
—
0
9
(3027035) Albumin [Mass/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.3
—
142.2
—
0
6
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
14
105
1.34
0.41
1.1
1.4
pmol/l
83.7
76.0
—
6
37
(3044007) Cell count panel - Peritoneal fluid
8
60
1.33
0.40
1.3
2.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
35
1.43
0.39
1.4
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
203
0.79
0.38
1.4
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
12
89
1.35
0.38
1.7
1.6
—
7.9
—
0
5
(3016018) Differential panel - Cerebral spinal fluid
20
161
1.24
0.37
1.7
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
90
1.34
0.35
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
127
1.26
0.33
1.6
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
22
182
1.21
0.33
1.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
87
0.69
0.33
1.3
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
74
1.35
0.32
1.2
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
74
1.35
0.32
1.2
1.4
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
6
47
1.28
0.32
1.3
1.5
mmol/l
2.3
3.3
—
6
42
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
187
0.80
0.32
5.4
4.4
—
—
—
0
0
(3035880) pH of Pleural fluid
12
92
1.31
0.31
1.2
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
101
1.29
0.31
1.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
52
1.35
0.31
1.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
153
0.78
0.30
1.1
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
410
0.88
0.30
1.2
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
22
185
1.19
0.29
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
107
0.75
0.29
1.5
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
32
366
0.87
0.29
2.2
1.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
44
393
1.12
0.28
3.3
2.9
umol/l
37.2
35.8
0.10
36
337
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
103
1.26
0.28
1.0
1.2
—
—
—
0
0
(4281824)
15
183
0.82
0.27
1.2
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
36
318
1.13
0.27
1.2
1.4
—
17.1
—
0
9
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
221
2116
1.05
0.27
1.5
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
128
0.78
0.26
1.7
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
19
159
1.20
0.26
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
19
159
1.20
0.26
1.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
19
159
1.20
0.26
1.3
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
71
0.70
0.26
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
77
1.30
0.26
1.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
72
0.69
0.26
2.0
2.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
160
0.81
0.26
2.2
2.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
49
444
1.11
0.25
1.5
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
19
224
0.85
0.25
1.2
1.4
e6/l
2034.5
1702.4
0.17
13
158
(4094501)
44
487
0.90
0.25
1.0
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
92
0.76
0.22
2.4
3.4
u/l
233.6
204.0
—
7
92
(3003740) Influenza virus B Ag [Presence] in Specimen
19
221
0.86
0.22
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
19
221
0.86
0.22
1.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
95
0.74
0.22
1.9
2.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
79
1.27
0.22
2.5
2.6
u/ml
1047.8
1428.3
—
10
79
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31
276
1.13
0.22
1.1
1.2
u/ml
282.8
287.3
0.03
14
172
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
41
1.22
0.22
2.4
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
15
178
0.84
0.22
1.2
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
199
0.85
0.21
1.1
1.4
e6/l
66399.6
113496.1
—
7
123
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
107
1.22
0.21
1.5
2.0
—
—
—
0
0
(4133840)
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
42
382
1.10
0.21
1.4
1.9
iu/l
5.5
5.0
0.08
13
123
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
6.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
5.2
—
—
—
0
0
(40758358) Immune stain study
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
14.6
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
154
1473
1.05
0.21
2.4
2.4
ug/l
5.1
7.5
2.44
138
1300
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
103
0.78
0.21
1.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
43
1.16
0.21
1.0
1.4
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
43
1.16
0.21
1.6
1.0
pmol/l
261.2
284.4
—
5
33
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
44
402
1.10
0.21
1.4
1.2
u/ml
39.3
7.5
—
5
69
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.0
—
0
7
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.0
—
0
7
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
17
145
1.17
0.20
1.3
1.4
u/l
374.5
346.5
0.07
17
139
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
48
1.25
0.20
2.0
1.4
ug/l
11.8
9.2
—
6
48
(3011288) Drugs identified in Urine by Screen method
16
187
0.85
0.20
1.8
3.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
17
146
1.17
0.19
1.0
1.0
u/ml
1.1
2.5
—
10
51
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
241
1.12
0.19
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
21
184
1.14
0.19
1.0
1.1
u/ml
0.2
1.2
2.39
11
66
(3023430) Cat dander IgE Ab [Units/volume] in Serum
16
137
1.17
0.18
1.0
1.1
u/ml
1.5
4.3
—
8
49
(3020891) Body temperature
74
697
1.06
0.18
6.1
4.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
43
396
1.09
0.18
1.4
1.2
u/ml
1.6
3.1
—
5
44
(3033799) Differential panel - Peritoneal fluid
7
61
1.15
0.17
1.4
2.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
61
1.15
0.17
2.9
2.5
—
—
—
0
0
(4035726)
160
1542
1.04
0.17
1.4
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
68
0.73
0.17
1.0
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
72
762
0.94
0.17
4.9
3.7
%
50.1
49.9
0.02
72
753
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
70
0.71
0.16
1.0
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
31
282
1.10
0.16
1.3
1.4
u/ml
122.0
126.4
—
5
56
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
70
1.14
0.16
1.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
13
111
1.17
0.15
1.1
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
73
1.10
0.15
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
93
974
0.95
0.15
1.2
1.2
iu/ml
68.1
147.2
4.03
34
353
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
224
0.89
0.15
1.2
1.3
—
—
—
0
0
(4027681)
9
83
1.08
0.14
1.4
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
97
0.82
0.13
1.1
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
170
0.88
0.13
5.0
3.5
%
56.3
56.6
—
9
117
(40768793) Breast Pathology biopsy report
35
377
0.93
0.13
1.3
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
24
218
1.10
0.13
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
54
570
0.95
0.12
1.6
1.7
mg/l
2.2
4.2
1.10
36
405
(3012441) Differential panel - Pleural fluid
20
181
1.11
0.12
1.3
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
34
317
1.07
0.12
1.2
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
38
356
1.07
0.12
1.4
1.3
miu/ml
231.8
210.4
0.09
12
160
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
39
366
1.07
0.11
1.4
1.4
e6/l
1489.1
711.7
0.27
30
290
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
39
366
1.07
0.11
1.3
1.4
e6/l
6.1
18.5
0.73
29
280
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
32
298
1.08
0.11
1.1
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
86
1.16
0.11
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
86
1.16
0.11
1.0
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
33
351
0.94
0.10
2.0
1.8
nmol/l
1.1
0.8
0.75
27
294
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
42
398
1.06
0.10
2.5
2.3
ug/min
54.9
115.7
0.95
20
255
(3019832) Treponema pallidum Ab [Presence] in Serum
73
703
1.04
0.09
1.4
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
348
3432
1.02
0.09
3.3
3.0
ug/l
0.6
0.8
4.59
247
2276
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
14
155
0.90
0.09
1.1
1.3
u/l
40.8
31.9
—
8
120
(3037556) Urate [Mass/volume] in Serum or Plasma
6
58
1.03
0.08
1.2
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
64
0.78
0.08
2.2
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
66
639
1.03
0.07
2.4
2.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
83
0.84
0.07
2.3
2.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
46
442
1.04
0.07
1.3
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
15
163
0.92
0.07
1.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
39
407
0.96
0.06
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
93
0.86
0.06
1.5
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
148
1.08
0.06
1.5
1.4
nmol/l
0.8
0.3
—
8
111
(3005570) Glucose [Moles/volume] in Urine
15
162
0.93
0.06
2.2
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
78
799
0.98
0.05
3.5
3.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
63
613
1.03
0.05
1.8
1.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
19
202
0.94
0.05
1.1
1.0
u/ml
1.9
2.1
—
5
82
(40768800) Prostate Pathology biopsy report
36
374
0.96
0.05
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
28
293
0.95
0.05
1.5
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
184
1819
1.01
0.04
3.4
4.3
ug/l
22.8
21.8
0.03
152
1518
(1617658) Protocol used for examination of sentinel lymph nodes
14
150
0.93
0.04
1.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
139
0.93
0.03
1.8
2.4
—
—
—
0
0
(3019225) pH of Specimen
164
1657
0.99
0.03
3.8
4.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
92
1.09
0.03
1.4
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
92
1.09
0.03
1.4
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
92
1.09
0.03
1.4
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
92
1.09
0.03
1.4
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
108
0.93
0.03
3.7
3.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
162
1.05
0.02
1.6
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
34
331
1.03
0.02
1.4
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
64
631
1.01
0.02
3.4
3.7
u/ml
52.1
2318.2
0.82
54
543
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
117
0.94
0.01
1.3
1.4
g/l
1.0
1.0
0.32
11
117
(3025130) Human papilloma virus identified in Specimen
15
143
1.05
0.01
1.5
1.9
—
—
—
0
0
(4034850)
56
568
0.99
0.01
14.9
9.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
213
1.03
0.01
3.2
2.5
—
—
—
0
0
(4024509)
15
144
1.04
0.00
1.9
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
155
0.97
0.00
1.6
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
19
185
1.03
0.00
1.3
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
111
0.99
0.00
1.5
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
141
0.99
0.00
1.1
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
28
275
1.02
0.00
1.5
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
29
295
0.98
0.00
1.5
1.8
—
—
—
0
0
(4146454)
19
189
1.01
0.00
2.8
2.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
17
174
0.98
0.00
1.8
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
30
296
1.01
0.00
1.5
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
70
702
1.00
0.00
1.1
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
67
668
1.00
0.00
2.0
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
28
278
1.01
0.00
1.2
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
102
0.98
0.00
2.0
2.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
22
222
0.99
0.00
1.1
1.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
108
1.02
0.00
1.6
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
30
298
1.01
0.00
1.5
1.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
58
577
1.01
0.00
2.7
3.3
g/l
0.3
0.3
0.07
27
240
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
1100.5
—
0
6
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
83
0.96
0.00
2.3
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
6
65
0.92
0.00
1.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
569.7
—
0
5
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
99
0.91
0.00
1.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
72
0.97
0.00
1.4
1.9
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
72
0.97
0.00
1.4
1.9
—
—
—
0
0
(44813793)
9
97
0.93
0.00
1.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3017400) Magnesium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
2.5
—
0
5
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
95
0.95
0.00
1.0
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
92
0.98
0.00
1.9
4.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
63
0.95
0.00
1.2
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
71
0.99
0.00
1.9
1.7
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
57
0.88
0.00
1.2
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
57
0.88
0.00
4.0
4.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
73
0.96
0.00
1.4
1.9
—
—
—
0
0
(44806420)
5
49
1.02
0.00
3.0
2.4
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint SCND_OTH_KNEEARTHROSIS and mortality.

Females

Parameter HR [95% CI] p-value
SCND_OTH_KNEEARTHROSIS 1.12 [1.01, 1.25] 0.038
Birth year 0.998 [0.99, 1.01] 0.606

During the follow-up period (1.1.1998 — 31.12.2019), 700 out of 4019 females with SCND_OTH_KNEEARTHROSIS died.

Males

Parameter HR [95% CI] p-value
SCND_OTH_KNEEARTHROSIS 0.972 [0.87, 1.09] 0.621
Birth year 0.987 [0.98, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 603 out of 3532 males with SCND_OTH_KNEEARTHROSIS died.

Mortality risk

Mortality risk for people of age

years, who have SCND_OTH_KNEEARTHROSIS.

N-year risk Females Males
1 0.11% 0.173%
5 0.715% 1.05%
10 1.69% 2.695%
15 3.183% 5.245%
20 6.244% 9.207%

Relationships between endpoints

Index endpoint: SCND_OTH_KNEEARTHROSIS – Other secondary gonarthrosis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data